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1. Introduction 
 
The focus of this work is centred on the study of endothelial progenitor cells (EPC) 
under various shear stress conditions. These cells are bone marrow-derived and 
circulate in the peripheral blood. They are able to differentiate into an endothelial-like 
cell type and participate in angiogenesis. Their discovery in 1997 by Asahara et al. 
initiated vast research in this field that yielded more than 10,000 publications in the 
past 15 years [1]. Furthermore, these progenitors are anticipated to act as a suitable 
substitute for endothelial cells (ECs) in tissue engineering because they are isolated 
easily from patients' blood and capable of differentiating into an endothelial cell 
phenotype. Interestingly, among all publications, hardly any dealt with EPCs 
cultivated under laminar shear stress and none approached effects of turbulence. 
This is astonishing considering that ECs represent the innermost layer of vessels. 
These cells are constantly exposed to laminar shear stress that results from blood 
flow within the vasculature. However, patients with arteriosclerosis, the main target 
group for EPC applications, may have anastomoses of previous graft surgical sites 
and also have atherosclerotic plaques that can both cause turbulent flow. Taking this 
into account, additional research on the effects of shear stress on EPCs is required 
and particularly on the effects of turbulent flow. With the goal of addressing this topic, 
EPCs were isolated from human peripheral blood and exposed to different shear 
stress conditions. A novel Taylor-Couette flow-based system was used to generate 
steady laminar shear stress and turbulence, while a parallel plate flow chamber 
served to apply pulsatile laminar shear stress on the EPCs. Moreover, the capability 
of EPCs to attach at a surface (a process termed homing) was also examined for all 
flow conditions. Furthermore, the feasibility of application of EPCs in tissue-
engineered constructs was tested. Research on this topic revealed new and 
unexpected effects of shear stress on EPCs which will be presented in the following 
chapters.  
The Taylor-Couette system and the pulsatile flow chamber turned out to be useful 
devices with high potential for shear stress research. For this reason, they were also 
further improved during this work which is fully described in the outlook chapter. 
However, to ensure continuity and comparability in this work, all shear stress 
experiments were performed using the initial devices instead of the improved 
versions. 
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To explain how important EPCs are, the crucial role of mature ECs must initially be 
pointed out. A first facet that indicates how important ECs are might be the fact that 
they coat all inner vessel surfaces within the human body. Astonishingly, an ordinary 
person of 70 kg weight has a total number of 1012 ECs that cover a surface area of 
about 1,000 m2 [2]. For better illustration, this equals the area highlighted by the red 
square in Figure 1 depicting the Berlin landmark, Brandenburger Tor.  
Figure 1 – Picture showing the landmark of Berlin, the Brandenburger Tor. The red 
square indicates an area of 1,000 m² that is equal to the total surface area on the 
inside of vessels in a 70 kg person.  All vessels in humans are covered by a confluent 
layer of approx. 1012 endothelial cells. Map from BingTM Maps (MicrosoftTM). 
This vast coating of ECs is called endothelium. Endothelium is not just a passive 
barrier for blood but rather a bio responsive surface that influences the blood flow 
through vessels. Endothelial cells generate anti-thrombotic or pro-thrombotic factors 
in order to control coagulation.  Anticoagulation is mainly, but not solely controlled by 
regulation of the serine protease, thrombin. There are also other factors involved in 
this well-adjusted process. A healthy endothelium displays an anti-thrombotic profile. 
Pathophysiological conditions enhance the potential of ECs to promote clotting of 
blood. Then, production of tissue factor is elevated. Tissue factor is known to 
radically promote activation of certain factors from the coagulation cascade and by 
this method influences the function of thrombin [3].  
Another very important aspect of ECs is their ability to actively regulate vasodilatation 
and vasoconstriction by influencing contraction and relaxation of smooth muscle cells 
resident in the media region of the vessel wall. Vasodilatation means that smooth 
muscle cells relax and the vessel increases its diameter. The consequence is a 
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reduced vascular resistance and a higher blood flow [3]. One of the most important 
agents, nitrogen oxide (NO), is released readily by ECs under normal conditions, but 
production of NO changes with exposure of the endothelium to different shear stress 
[3]. 
Vasculogenesis is the generation of vasculature during embryogenesis without the 
presence of any existing vascular structures. Angiogenesis describes remodelling of 
the vessel wall with the aim to grow new vessels from already existing adult 
vasculature.  In both processes, ECs play a key role. Genetic knock-out of factors 
that regulate one of these processes ended in a fatal phenotype in mice [3]. 
 
Considering all presented properties of these cells, it becomes clearly obvious how 
indispensable to life ECs are. Consequently, the enormous impact of the 1997 
published paper of Asahara et al. “Isolation of putative progenitor ECs for 
angiogenesis” [1] becomes reasonable. In their work, they described a method to 
isolate a potential progenitor cell for ECs from blood, a cell type that was later named 
EPC. EPCs were reported to derive from a hematopoietic lineage and to possess a 
higher proliferative potential compared to mature ECs, although this is only half the 
truth. Subsequent studies elaborated that EPCs are rather a heterogenous 
population of cells. Primarily, two different phenotypes could be identified within 
EPCs from one cell isolation. Hence, early and late outgrowth EPCs that varied in 
phenotype and proliferative potential were described. Only one of those cell types 
has a hematopoietic profile, while the other resembles the phenotype of a mature 
endothelial cell.  
The interest of the scientific community in EPCs was intense, as they not only proved 
to have an endothelial phenotype but also exhibited hematopoietic potential. The field 
of application is very broad. Of interest, EPCs have been employed in cardiovascular 
regeneration setups to the utmost extent, which will be described in the following 
chapters in more detail. Briefly, apart from their role in ischemia, EPCs have mainly 
been used to restore damaged endothelium or employed to grow an alternative cell 
coating for vascular grafts and stents. In view of the important response of mature 
ECs to shear stress, only few studies have been performed, in comparison to the 
enormous residual body of research on this field. In addition, apparatuses used for 
investigation of shear stress generation were afflicted with technical weaknesses. 
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1.1. Endothelial progenitor cells (EPCs)                                
 
The term “Endothelial progenitor cell (EPC)” implies a cell progeny that is able to 
differentiate into an endothelial cell-like phenotype. The existence of cells with this 
capacity has already been postulated in the 1960’s by Stump et al [4]. Dacron hubs 
that had been positioned in the aortic blood stream of pigs for at least 20 days were 
covered by endothelial-like cells at time of explantation. The polyethylene suture 
fixing these hubs to the wall was not covered by any cells. Hence, Stump and his co-
workers supposed that ECs had not migrated from the side of the suture but rather 
were those endothelial-like cells on the hubs derived from the blood. Thereafter, it 
took more than 30 years until in 1997 Asahara et al. described a cell population that 
originates from blood and can differentiate into an endothelial-like cell type in vitro [1]. 
Furthermore, they showed that these cells were able to form tubes on Matrigels and 
also home to ischemic areas. Thereafter, the term EPC (Endothelial Progenitor Cell) 
arose in the literature, and with it a heated debate about the identity and origin of 
these cells. After more than 10 years, there is still no distinct marker for the EPC 
population even though numerous approaches to define this cell type can be found in 
the literature. Commonly, a combination of “markers” is used to identify the 
investigated cell population. Examples of markers in this context are: epitopes on the 
cell surface, the uptake of distinct chemicals, metabolic properties, morphological and 
growth characteristics. Usually a set of markers for hematopoietic and endothelial cell 
lineages are combined to describe the phenotype of endothelial precursors. 
In the first report from Asahara et al. [1], cells were positive for CD34, KDR, CD31, 
CD45 and showed spindle-shaped morphology after one week of cell culture. The 
function of CD34 is not exactly known but it is supposed to function as an adhesion 
protein [5]. It is routinely used for specific selection and isolation of hematopoietic 
stem cells from blood [6]. Moreover, it is also found on vascular ECs [5]. KDR (Flk-1 
CD309, VEGF-R2) is a receptor for VEGF (vascular endothelial growth factor) and is 
expressed on hematopoietic stem cells [7-9] and ECs [8, 10]. CD31, also known as 
PECAM-1 (Platelet endothelial cell adhesion molecule 1), is used as a phenotypic 
marker for endothelial cells. The PECAM-1 protein is important for cell-cell junction 
formation between endothelial cells. Moreover, it is also involved in the regulation of 
leukocyte trafficking though the endothelial vessel wall [11, 12]. In addition to CD34, 
KDR and CD31, Asahara et al. used CD45 (leukocyte common antigen) to monitor 
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the developmental progression of isolated cells towards an endothelial-like 
phenotype. Interestingly, flow cytometry measurements revealed that almost 95% of 
freshly isolated cells were CD45-positive. In contrast to this, cells showed no 
expression of CD45 after 7 days of culture. To further validate the endothelial 
phenotype of the investigated cells, expression of two additional endothelial specific 
proteins, Tie-2 and E-selectin, was also measured with flow cytometry. The levels of 
both proteins were higher after one week of culture than among freshly isolated cells. 
It has been shown that Tie-2 is crucial for both the early embryonic development of 
ECs and the homeostasis of adult ECs [13]. The adhesion molecule E-selectin is also 
a very reliable marker as it is exclusively expressed on ECs [14]. Binding capability 
for ulex europaeus agglutinin–1 (UEA-1) and uptake of acetylated low density 
lipoprotein (ac-LDL) were also explored. It is well known that UEA-1 specifically binds 
to L-fucose on the surface of ECs and thus can serve to discriminate them from other 
cell types [15]. Besides, only macrophages and ECs take up ac-LDL through the 
scavenger pathway by endocytosis - a specificity that is often used for isolation of 
ECs [16]. In addition to all aforementioned markers, the expression of endothelial 
nitrite oxide synthase (eNOS) and the synthesis of nitrite oxide (NO) after 
acetylcholine stimulation were also measured. Expression of eNOS was semi-
quantitatively confirmed by RT-PCR (reverse transcriptase - polymerase chain 
reaction). The production of NO by ECs is crucial for the proper function of an intact 
endothelium. The release of nitrogen oxide regulates the smooth muscle cell (SMC) 
layer deep to the endothelial cell layer. An increase in NO levels led to a relaxation of 
the SMCs. This process is called vasodilatation and it is very important for the 
regulation of blood flow [17, 18] which is used already for clinical application. In 
conclusion, Asahara et al. characterized an endothelial precursor cell type that has a 
hematopoietic offspring and differentiates with time into an endothelial cell-like cell 
type that has been characterised using a huge spectrum of markers. However, as the 
hematopoietic markers CD34 and KDR are also present on adult endothelial cells, 
there was still need for a marker that was solely present on hematopoietic cells. With 
CD133 (AC133, Promin-1), Peichev et al. introduced a marker for EPC definition that 
is not exclusively expressed on hematopoietic cells, but on some other cell types as 
well [19-21]. Advantageously, CD133 is not expressed on ECs at all. This allows one 
to distinguish between bone marrow-derived hematopoietic cells and ECs that could 
have been shed from the native endothelium lining of vasculature [22]. Plugs from 
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Matrigels have been used for tube formation analysis – another method to classify 
EPCs.  
Although there is still a lack of a final and clear definition for EPCs, the presented set 
of markers allows one to define at least a well circumscribed working population of 
cells. This is very useful in order to generate comparable data between different 
workgroups.    
 
1.1.1 Origins of EPCs 
 
This chapter gives an overview about the origins and the mobilization of EPCs. 
Knowing factors that either promote or impair cell mobilization has allowed 
researchers to control this process and thereby regulate the levels of circulating 
EPCs in peripheral blood.  
Thus, for applications with clinical relevance, the level of circulating EPCs is 
important [23, 24]. Usually the number of circulating EPCs in the peripheral blood is 
low. Most progenitor cells reside quiescent in the bone marrow (BM) within a region 
named the stem cell niche. Mobilization of EPCs depends on the interaction of many 
factors and is still under intense research. NO (nitrogen oxide), released by nNOS 
(neuronal nitrogen oxide synthase), can activate MMP-9 (matrix metalloproteinase 9) 
via S – nitrosylation [25]. Thus, it is likely possible that a nitrogen oxide synthase 
inside the stromal niche can similarly influence MMP-9. This proteinase has been 
shown to have a major role in progenitor cell mobilization since it cuts off sKitL 
(soluble Kit ligand) from mKitL (membrane-bound Kit ligand), which is expressed on 
the surface of stromal cells [26]. The sKitL is a cytokine that is also known as “steel 
factor” or “stem cell factor (SCF)”. Once released, sKitL can bind to cKit (CD 117), a 
receptor tyrosine kinase III expressed by many progenitor cell lines and especially by 
hematopoietic stem cells. Binding of sKitL stimulates the dimerization and 
subsequent autophosphorylation of cKit [27]. This activates the cKit receptor, thereby 
leading to induction of further signal transduction cascades and consequently 
initializing the release of progenitors from the stem cell niche. Subsequently, free 
progenitor cells enter peripheral circulation which is, unlike the stem cell niche, a 
permissive environment and allows these cells to differentiate. There are many 
agents under active research with potential to mobilize EPCs. Among those are SDF-
1 (stromal derived factor – 1, also known as CXCL12), AMD3100 (an artificial agent), 
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G-CSF (granulocyte colony stimulating factor), CY (cyclophosamide), GM-CSF 
(granulocyte monocyte stimulating factor), VEGF (vascular endothelial growth factor), 
Ang-1 (angiopoietin-1), EPO (erythropoietin), statins, PPARγ (peroxisome 
proliferation-activated receptor γ) agonists, estrogens and calveolin-1. Physical 
exercise can also increase levels of circulating EPCs [28-42].  
In conclusion, the number of EPCs can be raised by various different and 
independent pathways and stimuli. However, one has to be careful when interpreting 
the results as they derive from different in vitro models, animal experiments and 
human studies. Still, these results provide clues which are useful when trying to 
mobilize EPCs from the stem cell niche. Further studies in the organism of interest 
could then help to elucidate the transferability of the presented results.  
 
 
1.1.2 Phenotypes of EPCs 
 
There are thousands of publications about EPCs in diverse applications and scientific 
fields. There are also very convincing attempts to define the phenotype of an EPC 
[43-49]. Unfortunately, until now there is no consent on this issue and therefore “the 
lack of a clear definition for an EPC” is repeated prayer-mill-like in almost every 
publication dealing with endothelial progenitor cells. One of the most heatedly 
discussed points, that was postulated already in initial publications, is whether EPCs 
really derive from the hematopoietic lineage [1, 19, 50]. Another open question is if 
the extremely rare population of cells within circulation can influence anything at all.  
To conclude, a final, reliable and accepted definition for these cells has not been 
generated by a single person or workgroup.  
For this reason, only two populations of EPCs relevant for this work will be presented 
in the following chapters instead of a further attempt to define "the EPC". 
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1.1.2.1 Early outgrowth EPCs 
 
Mononuclear cells are isolated from peripheral blood and are grown in endothelial 
medium for micro-vascular endothelial cells. Subsequently, the first colonies of cells 
appear after 7 days of cell culture. This is where the name “early outgrowth EPC” 
derives from. These early outgrowth cells express hematopoietic markers and have a 
low potential for proliferation. Thus, they were reported to be more 
monocyte/macrophage-like, but still able to exert positive paracrine effects on cells to 
which they bound. Moreover, they lack the ability to form tubes in mice in vivo [51-
53].  
 
1.1.2.2 Late outgrowth EPCs 
 
Isolation of cells for late outgrowth EPCs is identical to that of early EPCs. The time 
of cultivation is crucial to obtain the right phenotype. Late outgrowth EPCs do not 
appear before a cultivation time of at least 3 weeks. They have substantial 
divergence compared to early outgrowth EPCs. Late EPCs have significantly higher 
potential for proliferation and are capable of tube formation in vivo. In addition, they 
encompass endothelial markers and are more similar to mature endothelial than to 
hematopoietic cells [53-56]. Therefore, late outgrowth EPCs were the focus of this 
body of work.  
 
1.1.3 Clinical application of EPCs 
 
EPCs have already been used for numerous medical purposes and clinical studies. 
Firstly, the number of EPCs in patients’ blood could be successfully correlated with 
outcome in different diseases. Secondly, EPCs often serve as the cell source for the 
lining of replacement vessels. Finally, it has been shown by Asahara et al. that EPCs 
can home to ischemic areas and form capillary networks [1]. EPCs are also of 
interest for reperfusion research and for investigation in the field of angiogenesis and 
in tumour biology.  
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1.1.3.1 EPCs as clinical markers 
 
One of the least invasive methods to employ endothelial progenitors in medical 
research is their use as marker. Scientists in various fields of research are already 
using EPCs as indicators and correlate their count or expression profile 
retrospectively with outcome or progression of the regarded illness. 
 
In two recent reviews, the use of EPCs as a clinical marker has been very intensively 
discussed. Resch et al. [43] presented an overview about the latest clinical studies 
dealing with number of EPCs as a marker. Sen and co-workers [57] emphasized that 
not only the number of endothelial progenitor cells in blood circulation is important, 
but even more the functional aspect of these cells (see tables 1 and 2). Considering 
this, the absence of a unique definition for the EPCs is still hindering a reliable 
comparison between studies. However, the use of EPCs from either subpopulation 
has proven to be feasible in most studies. Even though the cells utilised are not 
clearly “the EPC population”, it was possible to correlate their count with outcome of 
that specific disease in a clinical study.  
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Table 1 - Summary over recent studies on EPC count and disease outcome 
 
Disease entity 
Patients/ 
model 
EPC 
levels 
EPC definition Publication 
Risk factors for coronary Artery 
disease 
45 ↓ 
DiLDL uptake, KDR, vWF, eNOS, 
CD45, CD133, CD34 
Vasa, 2001 
Patients at increased 
cardiovascular risk 
519 ↓ CD34+/KDR+/CD133+ Werner, 2005 
Hyperhomocysteinemia 30 ↓ 
AC133+ KDR+; DiI-acLDL uptake and 
lectin staining 
Zhu, 2006 
Cardiac syndrome X 12 ↓ 
VE-cadherin, CD31, vWF, DiI-acLDL 
uptake and lectin staining 
Huang, 2007 
Coronary artery disease 104 ↓ CD34 + CD133 + VEGFR-2+ Wang, 2007 
Acute myocardial infarction 10 ↑ 
CD34+, KDR+/CD34+, CD133+/CD34+ 
and CD117+/CD34 + CPC 
Grundmann, 2008 
Dilated cardiomyopathy 65 ↑ 
CD133(+)/CD34(+) cells. Phagocytized 
DiI-acLDL and binded FITC-UEA-I 
Zhou, 2008 
Congestive heart failure 26 ↓ CD34+ MNCs Nonaka-Surukawa, 2007 
Patients with stable angina + 
renal insufficiency 
102 ↓ CD34(+)/KDR(+) Surdacki, 2008 
Peripheral vascular disease 
DMII 
51 ↓ CD34+, KDR+ Fadini, 2005 
Diabetes 
Mouse 
model 
↓ c-Kit+/Sca-1+/Flk-1+ Kang, 2009 
DM I 20 ↓ CD31, DiLDL uptake, ((UEA)-1) Loomans, 2004 
Obesity 149 ↓ KDR/CD34, CD133/CD34 Müller-Ehmsen, 2008 
Chronic kidney disease 19 ↓ Tie-2+ or VEGFR-2+ cells Rodriguez-Ayala, 2006 
Chronic renal failure 44 ↓ 
DiLDL, (UEA)-1 lectin, KDR, vWF, NO 
synthesis 
Choi, 2004 
End-stage kidney disease 45 ↓ 
“Type I EPC” (CD34 + KDR+) and 
“Type II EPC” 
Westerweel, 2007 
Long-term hemodialysis 20 ↑ 
(CD34+, CD34+/CD133+, CD34+/KDR 
+ cells) 
Herbrig, 2004 
Allogeneic cardiac 
transplantation 
15 ↓ 
CD31, (VE)-cadherin, vWF, KDR, Tie-
2, CD34 
Simper, 2003 
Chronic graft versus host 
disease with skin leasons (s-
cGVHD), PSS 
27 ↓ CD34(+)/CD133(+)/KDR(+) Shimura, 2008 
Idiopathic pulmonary arterial 
hypertension 
20 ↓ AC133 + KDR+ Junhui, 2008 
Bronchopulmonary dysplasia 
in preterm infants 
98 ↓ CD34 CD133 VEGFR-2 Borghesi, 2009 
Rheumatoid arthritis 13 ↓ 
CD34(+), CD34(+)/CD133(+), and 
CD34(+)/KDR(+); (VE-cadherin, 
DiLDL) 
Herbrig, 2006 
Psoriatriasus and psoriatric 
arthritis 
32 n. CD34/133 and CD34/KDR Ablin, 2009 
Acute stroke 136 ↑ CD133/KDR Zhou, 2009 
Migraine 92 ↓ CD34, VEGFR 2, CD31, acLDL uptake Lee, 2008 
Alzheimer disease 55 ↓ CD34+/KDR + or CD133+ Lee, 2009 
Depression 33 ↓ 
Mature (CD34+/VEGFR2+) and 
immature (CD133+/VEGFR2+) EPC 
counts 
Dome, 2009 
Pre-eclampsia 14 ↓ 
AC133+/KDR+; DiI-acLDL uptake and 
lectin staining 
Xia, 2007 
Pre-eclampsia 8 ↓ 
von Willebrand factor, KDR/Flk-1, 
CD31, and ecNOS; acLDL uptake, 
Sugawara, 2005 
Pterygium 28 ↑ CD34(+) and c-kit(+) Lee, 2007 
Avascular necrosis of femoral 
head 
54 ↓ 
CD34+/VEGFR2+, DiI-acLDL uptake 
and lectin staining 
Feng, 2009 
Table 1 from Resch et al. [43] and gives a summary over recent studies on EPC 
count and disease outcome.   
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Table 2 - Summary over recent studies on count EPC and disease outcome that 
also include the quality of the cells  
 
Disease EPC number EPC function Publications 
CAD ↓ ↓ Walter (2005), Werner (2007), Keynel (2008) 
Ischaemic cardiomyopathy early ↑   later ↓ ↓ Heeschen (2004), Vagimigli (2004) 
Diabetes ↓ ↓ 
Tepper (2002), Coomans (2004), McCabe(2007), 
Busik(2009) ,Loomans (2009), Brunner (2009), 
Hamed(2009),Chen Q.(2009), Oikawa (2010) 
Hypercholesterolaemia ↓ ↓ 
Asahra(1999),Vasa(2001), Dimmeler (2001), 
Imanischi (2003) ,Imanischi (2004), Chen J.Z. 
(2009) 
pertension ↓ ↓ 
Vasa (2001), Fadini (2007), Olivieras (2008), Zhou 
(2010), Giannotti (2010), Magen (2010) 
Smoking ↓ ↓ Vasa (2001), Kondo (2004), Michaud (2006) 
Aging ↓ ↓ 
Rauscher (2003), Heiss (2005), Tao (2006), Chang 
(2007) 
Rheumatoid arthritis ↓ ↓ Grisar (2005), Herbrig (2006) 
Inflammation ↓ ↓ Verma (2004), Gerorge (2004), Vagimigli (2004) 
Chronic kidney disease ↓ ↓ 
Choi (2004), Locatelli (2004), Herbrig (2004), de 
Groot (2005), Herbrig (2006) 
Pulmonary hypertension ↓ ↓ Wang (2007), Marsboom (2008) 
Table 2 from the publication of Sen et al. [57]  (modified) also takes the quality of 
EPCs into account, in addition to their count. 
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1.1.3.2 Homing of EPCs in angiogenesis and infarction models 
 
Many workgroups have already shown that the infusion of EPCs is a very promising 
approach to improve the revascularisation of ischemic areas. Murohara et al. found in 
an animal model for hind limb ischemia that EPCs contribute to revascularisation 
[58]. Kalka et al. investigated the effects of human EPCs that were injected into nude 
mice with induced ischemia in one leg. Mice that had received transfusion of 
heterologous EPCs showed a significantly higher rate of revascularisation and 
reperfusion in the affected limbs [59]. Kawamoto et al. distinguished the benefits of 
the progenitor cells for the cure of myocardial infarction in their studies. In two 
different animal models, they elucidated how EPCs improved the function of ischemic 
cardiac tissue [60]. Similar results were already obtained previously by Kocher et al. 
who also observed positive effects of progenitor cell treatment after myocardial infarct 
[61]. Infusion of EPCs seems to be a very promising approach to fight the damage 
after infarction in various tissues. Considering this, one does not wonder that there 
are already first clinical human studies on this topic. Assmus et al. discovered that 
the intracoronary application of autologous EPCs appears to be a feasible method 
augmenting regenerative processes after infarction [62]. These reports are just a 
number of examples to give a short overview and emphasize the important role of 
EPCs in this clinical field.  
 
1.1.3.3 EPCs as cell source for grafts or as lining for grafts in tissue 
engineering   
 
Proper function of vessels depends strongly on integrity of the inner monolayer of 
endothelial cells. As these cells resemble the inner lineage and come in contact with 
the blood stream, their main task is to maintain hemocompatibility thereby preventing 
thrombus formation and stenosis. If the integrity of this monolayer is disturbed for any 
reason, atherosclerosis might be the consequence resulting in clot formation and 
occlusion of the vessel, leading to subsequent infarction of the supplied tissue in the 
worst case with potentially lethal outcome. Thus, upkeep and proper regeneration of 
an injured endothelial cell monolayer is of crucial importance. A recent study 
questioned the benefits of EPCs in context of vascular regeneration and even 
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outlined that EPCs might contribute to atherosclerosis [63]. However, EPCs were 
already successfully used as a lining for vascular grafts, stents or other constructs 
and they improved hemocompatibility, reducing the formation of neointima and 
therefore promoting the patency [64-67]. This proves that pre-seeding of grafts or 
stents with EPCs is feasible. However, ex vivo pre-seeding necessitates expensive 
and time-consuming individual cell culture, including risk of contamination during 
storage. With the aim to avoid these difficulties, some workgroups developed 
strategies for in vivo seeding of grafts. Anti-CD34 antibodies were used as a coating 
for conduits to selectively capture cells from the bloodstream that carry the CD34 
epitope. A study with ePTFE grafts yielded a confluent monolayer, but there was an 
elevated level of intimal hyperplasia as well [68]. Adverse results were found by Aoki 
et al. who coated bare metal stents with anti-CD34 antibodies [69]. The stents bound 
EPCs in vitro and in vivo as well. In contrast to the ePTFE grafts, there was a 
reduction of neointima formation instead of an increase. Additionally, it was shown 
with first human trials (HEALING – FIM study) that the EPC capturing stents are 
feasible and safe. Stents coated with anti-CD34 antibodies are already commercially 
available from the company OrbusNeichTM under the name Genous Bio-engineered 
stent (www.orbusneich.com on 2011-12-11). Recently, the feasibility and safety of 
the stent have been challenged in a separate study: TRIAS HR (TRI-stent 
adjudication study-high risk of restenosis) [70]. The EPC capturing stent was 
compared with commercially available state of the art bare metal and drug eluting 
stents for application in high risk restenosis patients. Preliminary results after one 
year of study duration are alarming as the EPC capturing stent reveals to have twice 
as much target lesion failure (TLF) compared to the drug eluting stent (17,4% vs.7%). 
Nevertheless, the drug eluting stent still impairs re-endothelialisation and therefore in 
long term studies, the EPC capturing stent will be favourable.  
 
Another advance, also aiming to capture EPCs, was made using aptamers. Aptamers 
are single-stranded nucleotide sequences that can bind specifically to structures of 
choice i.e. synthetic molecules, peptides, proteins and even whole cells. The search 
for suitable aptamers is based on a process called SELEX (systematic evolution of 
ligands by exponential enrichment). The specific search for EPC capturing aptamers 
is based on a screening for CD34-positive cells by means of flow cytometry [71]. Due 
to their simple chemical synthesis and structure, aptamers can be reproduced with 
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ease and modified in a way that they obtain increased bioavailability, better 
pharmacokinetics or protection groups against nuclease digestion. Although 
aptamers were shown to “catch” CD31-positive EPCs from blood in vitro [72], it is not 
yet fully understood how this functions in detail. Presumably, binding is dependent on 
the spatial distribution and binding moieties of the nuclide acid sequence of the 
aptamers. 
There have also been attempts to use the amino acid sequence RGD (arginine, 
glycine, aspartic acid) in order to attract EPCs to a drug eluting stent [73]. RGD is a 
conserved motif found in various proteins of the extracellular matrix, e.g. fibronectin. 
Integrins on EPCs have a high binding affinity for this sequence. Porcine in vitro and 
in vivo studies demonstrated that RGD promoted stimulation of outgrowth, shear–
resistant recruitment and selective invasion potential of EPCs. Furthermore, an 
effective re-endothelialisation was achieved comprising infused porcine progenitors 
as well as endogenous CD34 positive cells. Subsequent survey for vessel occlusion 
revealed that after 12 weeks, the mean neointimal area and the cross-sectional area 
stenosis in the RGD loaded stent were significantly lower than in the unloaded or 
bare metal stents. Thus, proof of concept for the innovative approach of a RGD-
loaded drug eluting stent was presented.  
Finally, this field of research is very new and all methods for in vivo capturing of 
grafts still bear problems. However, regardless of the method employed, it appears 
obvious that a layer of these cells exhibits positive effects. 
 
1.1.4 Shear stress and EPCs 
 
Considering the vast amount of literature on EPCs, there are surprisingly few 
publications that focus at the influence of shear stress on these cells and there are 
no current studies examining the influence of turbulence. This is even more 
remarkable bearing in mind how important the influence of shear stress is with regard 
to mature ECs [74]. This chapter gives detailed overview on the field of shear stress 
research with EPCs. 
Initial investigations on shear stress were made with cultures of human peripheral 
blood-derived early EPCs that were repetitively cultured for 24 h under low shear 
stress ranging from 0.1 – 2.5 dynes/cm², depending on their localization on the dish 
within the rotating disc apparatus [75]. EPCs cultured under static conditions 
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remained without any defined orientation. EPCs cultured under shear stress on the 
other hand became elongated and oriented their long axis in the direction of flow 
after 24 h. Additionally these cells were positive for ac-LDL uptake and UEA-1. These 
changes were reversed after 24 h under static conditions. 
Cell density increased much more rapidly in the shear stress setup and was 
significantly higher from the 8th day onwards when compared to static culture. Cell 
cycle analysis revealed that under shear stress conditions, significantly more EPCs 
were in the S, G2 and M phase than in C0/G1. Therefore, laminar shear stress 
stimulated the proliferation of EPCs as well. After 4 days of static culture, shear 
stress was applied for 24 h on days 5, 7, 9, 13 and 20. Corresponding flow cytometry 
analysis on the following days demonstrated that shear stress accelerates the 
increase of expression levels of KDR, Flt-1 and VE-Cadherin. Results supporting 
these findings were obtained by RT-PCRs for KDR, Flt-1 and VE-Cadherin 
expression levels. The authors demonstrated the up-regulation of these endothelial 
specific markers under shear stress conditions. Besides, higher shear stress (1.4-2.5 
dynes/cm²) had a more influence than low shear stress (0.1-1.3 dynes/cm²). 
Interestingly, the formation of tubular structures on Matrigels could already be 
observed on the first day in shear stressed cells, but not until the fourth day in static 
EPC culture. This positive effect was still present one week after shear stress 
conditioning of the cells.  
Another publication focused mainly on the effects of shear stress on the production of 
nitrogen oxide (NO)  [76]. EPCs from human peripheral blood were isolated and 
cultured on a micro porous polyurethane vascular graft prosthesis that was pre-
coated with an aqueous photo reactive gelatine layer [77, 78]. This graft was 
mounted in a perfusion setup, where medium was pumped through by a peristaltic 
pump to generate shear stress. Depending on the flow velocity, different shear stress 
rates were achievable. Experiments were performed at 5, 15 and 25 dynes/cm² and 
the NO production was measured for each shear rate after 20, 40, 60, 120, 180 and 
240 mins. Additionally mRNA expression levels of eNOS were checked.  
EPCs showed a dose-dependent increase in NO production and elevated expression 
of eNOS. Thus, the amount of nitric oxide was about ~4-fold, ~6-fold and ~9-fold 
above the level of the static cultured control for 5, 15 and 25 dynes/cm², respectively. 
In addition, NO production kinetics was reported to be similar to that of shear 
stressed mature endothelial cells. After 60 min of shear stress incubation, the 
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quantity of NO reached a plateau and was maintained for the following 180 mins. The 
eNOS mRNA expression levels were about 2-fold, 2.8-fold and 3-fold at 5, 15 and 25 
dynes/cm², respectively. As the increase in eNOS transcription was less than the 
measured production of NO, the authors postulated that other mechanisms or factors 
that account for this discrepancy.  
A successive study took t-PA (tissue type plasminogen activator) secretion of 
sheared human peripheral blood derived EPCs into account [79]. T-PA is a serine 
protease that cleaves plasminogen into plasmin. Plasmin on the other hand, is an 
activator of fibrin lysis and has, therefore, anti-thrombogenic potential. There is still 
ongoing debate as to whether shear stress increases [80, 81]  or suppresses [82, 83] 
t-PA secretion of mature endothelial cells. However, the aim of the study was to raise 
t-PA secretion of EPCs by shear stress, in order to enhance their anti-thrombogenic 
potential and to improve the patency rate of in vitro seeded conduits.  Poly porous 
polyurethane grafts were seeded at a density of 1x105 cells/cm² and pre-cultured 
under static conditions for two days in advance of shear stress experiments in a 
previously established setup [78].  
Adherent cells were subjected to shear stress of 5, 15 and 25 dynes/cm² for 25 h. 
After 10, 15, 20 and 25 h, cumulative t-PA secretion was significantly higher at shear 
stress rates of 15 and 25 dynes/cm² than in the static control or at 5 dynes/cm². In 
addition, after 25 h of shear stress exposure, mRNA levels for t-PA were significantly 
elevated at 15 and 25 dynes/cm² when compared to static control or 5 dynes/cm². 
Moreover, all grafts that had been pre-seeded with shear stressed EPCs remained 
patent after two months, while five out of nine grafts that were pre-seeded with EPCs 
from static culture were occluded at that time point. The luminal surface of grafts from 
the shear stressed group showed a confluent cell monolayer with cells oriented in 
direction of flow after two months. Distinct to this, control grafts lacked this layer and 
showed formation of thrombi in SEM images.  
In conclusion, this study demonstrated a significant influence of shear stress on t-PA 
secretion of EPCs after at least 10 h and at a minimum shear stress of 15 dynes/cm². 
In addition, lining of grafts with shear stress pre-treated EPCs appears feasible and 
improves the patency of grafts in vivo. Similar to previous studies, the cells also 
obtained an elongated morphology. However, comparison of this data with results 
from mature ECs is hardly possible considering the discrepancy in aforementioned 
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studies of ECs [80-83]. It is therefore difficult to classify the results of the present 
work with EPCs. 
Another study with human EPCs concentrated on the piece of evidence that shear 
has an influence on Cu/Zn superoxide dismutase (SOD) [84]. Human Cu/Zn SOD is a 
cytosol resident enzyme that inactivates superoxide anions (O2
-). This enzyme might 
also play a major role in the regulation of bioactive NO. The influence of shear stress 
on Cu/Zn SOD was investigated with the previously described setup [76]. Expression 
levels of SOD mRNA were measured after 24 h of shear stress at 5, 15 and 25 
dynes/cm², respectively and correlated to those of statically cultured EPCs. Cu/Zn 
SOD activity increased depending on the degree of shear stress and with the 
duration of its application. Likewise, mRNA levels were found to increase with rising 
shear rates.  
 
A further publication with regard to EPCs under shear stress focused on co-cultures 
of human cord blood-derived EPCs and hVSMCs (human vascular smooth muscle 
cells) [85]. Shear stress experiments were performed in a parallel plate flow chamber 
at 5 dynes/cm² for 12 h. In order to investigate differentiation of EPCs from a 
progenitor-like cell type towards the endothelial lineage, expression of endothelial 
markers CD31, vWF and progenitor makers CD133,CD34 were measured by flow 
cytometry analysis. Moreover, functional analyses of Akt, a component of a signal 
transduction cascade for mechano-transduction, were performed using its specific 
inhibitor “Akti”. The most prominent differentiation towards the endothelial cell line 
resulted from the combination of co-culture and shear stress. Hence, endothelial 
markers CD31 and vWF were expressed at the highest level. At the same time, 
progenitor cell marker expression of CD133 and CD34 was reduced markedly. The 
highest level of phosphorylation of Akt was present in the combination of co-culture 
and shear stress. EPCs under shear stress or co-culture alone were phosphorylated 
to a lesser extent. All values were significantly higher than the static control. These 
findings were supported by flow cytometry results from Akt inhibition studies. In co-
cultured EPCs, inhibition with Akti led to a decrease of endothelial markers down to 
~24% for CD31 and ~80% for vWF. At the same time, expression levels for CD133 
and CD34 rose to ~170% and ~350%, respectively. Akt could be involved in shear 
stress-induced differentiation of EPCs towards the endothelial lineage, which 
conforms to findings from previous publications [86].  
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ECs in arteries and veins are exposed to different shear stress levels. Cells lining 
arterial walls express a different set of specific markers compared to cells from 
venous walls. To investigate whether EPCs differentiate into an arterial or venous 
phenotype of endothelial cells, human EPCs derived from peripheral blood were 
cultured under static and shear stress conditions and assayed by various methods 
[87]. The applied shear stress, generated by a rotating disc device, was not defined 
but rather ranged from 0.1 to 2.5 dynes/cm² and was applied for 6 and 24 h. EPCs 
under shear stress conditions had elevated mRNA levels for arterial endothelial cell 
specific markers: ephrinB2, Notch 1/3, Hey 1/2 (Hairy/enhancer-of-split related with 
YRPW motif protein 1/2) and ALK1 (activin receptor-like kinase 1). Quite the reverse 
was the decreased mRNA levels for specific venous endothelial cell markers, EphB4 
and neuropilin-2.  
Using the same medium with different viscosities, they demonstrated that shear 
stress response of ephrinB2 (and EphB4) is dependent on the mechanical force of 
fluid flow and not caused by improved mass transfer conditions that result from 
higher shear rates. Increased expression of ephrinB2 was a result of activated 
transcription and not of mRNA stabilization, which was shown by actinomycin D 
chase experiments and luciferase assays. The Sp1 consensus sequence within the 
cis-acting promoter region of the ephtinB2 gene was essential for the activation of 
transcription. The latter results were supported by different methods like mutation 
experiments, EMSA or ChIP assays. In conclusion, fluid shear stress at the 
aforementioned rate induces differentiation of EPCs towards the arterial phenotype of 
endothelial cells. 
It becomes obvious that shear stress plays a key role in promoting differentiation of 
EPCs towards the endothelial lineage. Nevertheless, it is important to take into 
account that aforementioned results derive from different studies and therefore 
important parameters diverged from issue to issue. Cell types used in previous 
experiments were either human peripheral blood EPCs [75, 76, 87] or human 
umbilical cord blood-derived EPCs [85]. In addition, there is still much controversy 
about the identity and correct definition of an EPC [88]. Furthermore, chosen shear 
stress rates varied from 0.1 to 25 dynes/cm² and times of exposure to shear stress 
differed from one experimental setup to another. In this context, devices employed for 
shear stress application also have to be examined closely as they all have certain 
inadequacies. The rotating plate device develops a gradient of shear stress from the 
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middle to the outer borders. Perfusion chambers make use of the parallel plate 
principle; therefore a relatively long distance is necessary to develop a nearly laminar 
fluid flow. Also, they are driven by peristaltic pumps and the resulting shear stress is 
pulsatile. Finally, flow loading devices that employ seeded artificial grafts require a 
large number of cells and might not have sufficient length to allow development of a 
proper laminar flow. To conclude, a comparison of results from studies applying 
different cells from various species and cell types while using different devices with a 
wide range of shear stress is hardly possible. Nevertheless, all studies point at a 
differentiation of EPCs towards an endothelial-like cell type under the influence of 
shear stress. No research has been performed yet on the effects of turbulence on 
EPCs.  
In conclusion, further research on the influence of shear stress on EPCs is necessary 
to estimate their potential for clinical application. In future studies, influence of 
turbulence should also be investigated in detail. Implanted grafts cause turbulent flow 
in the vessel due the anastomoses. In addition, grafts are usually implanted in 
patients with atherosclerosis where occlusions lead also to flow disturbances. 
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1.2 Shear stress devices 
 
This section provides insight into relevant topics of fluid dynamics for this work. After 
a short definition for shear stress, different concepts used for shear stress devices 
will be presented and compared. The focus will be on the Taylor-Couette flow-based 
system primarily used within this work.  
 
1.2.1 Shear stress - short definition 
 
Shear stress (τ) is a strain that is produced when layers of an object are subjected to 
opposing forces. For Newtonian fluids (like water), the magnitude of shear stress is 
proportional to the gradient of velocity also named shear rate (du/dy) multiplied by 
dynamic viscosity (μ). Hence, shear stress is calculated as (eq.1)  
 
                                   
  
  
                                     (eq.1) 
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1.2.2 Generation of shear stress with a Taylor-Couette system 
 
When dealing with Couette flow (named after Maurice Marie Alfred Couette † 18. 
August 1943 - a French physicist), it is important to distinguish two systems: a simple 
plane Couette system (Figure 2) and a more sophisticated Taylor-Couette system 
with two co-axial cylinders (Figure 3).   
 
Plane Couette system (or parallel plate flow chamber) 
 
 
Figure 2 – Schematic drawing of plane Couette system. A laminar flow pattern 
develops upon movement of the upper plate; Medium (red). 
 
A plane Couette system comprises two very long parallel plates with a defined 
distance (d) between them. The space in between is filled with fluid. Moving the plate 
on top at a defined steady velocity (u) while the other plate remains fixed generates a 
shear stress distribution that can be calculated with (eq.1).  
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Taylor-Couette system 
Figure 3 Schematic view of a Taylor-Couette system. The system consists of two 
coaxial cylinders with a common axis and fluid in between. 
 
 
A Taylor-Couette system comprises two coaxial cylinders with different diameters 
and was developed independently in parallel by Maurice Couette and Arnulph 
Mallock (1888) as a viscometer (Figure 3). 
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Later, Geoffrey Taylor (1923) made use of a Taylor-Couette system to investigate the 
transition of stable laminar fluid flow patterns to complex unstable and even turbulent 
flow regimes. The formation of a desired flow in a Taylor-Couette system depends on 
the different angular velocities of the cylinders relative to each other. There are 4 
possibilities for rotation of the cylinders (Figure 4). 
 
 
Figure 4 Overview of possible setups of Couette systems.  
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In the presented study, a bioreactor with a static outer cylinder and rotating inner 
cylinder was employed. At low speed, the flow regime is a laminar Couette flow 
(Figure 5 -1). However, with increasing angular velocity of the inner cylinder, 
centrifugal forces on the fluid begin to grow. Thus, the flow pattern is a result of the 
azimuthal and the centrifugal force, and Taylor vortices (named after G.I.Taylor 
(1923)) begin to develop. This flow regime comprises pairs of counter-rotating, 
toroidal flow cells that are axisymmetric and is also laminar although not stationary 
(Figure 5- 2/3). When the inner cylinder reaches even higher rotation speeds, the 
flow changes again and ultimately becomes turbulent. 
                             
 
Figure 5 Schematic drawing of Taylor-Couette systems with different flow patterns. 
Laminar azimuthal Couette flow (1), Taylor vortices (2). Detail view of counter-
rotating vortices (3)1.  
                  
 
                                            
1
 Figure from master thesis of Eva Cholewinski Helmholtz - Institute (RWTH Aachen University). 
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In the work of Andereck et al. [89], most transition of the flow patterns for possible 
Taylor-Couette setups have been described in detail and can be estimated by the 
Reynolds numbers of each cylinder (Figure 6). 
 
Figure 6 Overview for flow patterns within Couette systems described by Andereck et 
al. (1986). Red line indicates possible flow patterns for Taylor-Couette systems with 
inner rotating cylinder. 
 
The Reynolds number (Re) is dimensionless and describes the ratio between viscous 
and inertial forces. Calculation of the Reynolds numbers for both cylinders can be 
performed with (eq.2) and (eq.3), where ω is the angular velocity, ri is the radius of 
the inner cylinder, ra is the radius of the outer cylinder, and ν is the viscosity. 
 
  i  
             
 
                                      (eq.2) 
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  a  
             
 
                                    (eq.3) 
Each Reynolds number changes only with the angular velocity of a cylinder as the 
geometry of the system is fixed and the viscosity is also known. Negative Reynolds 
numbers appear in systems with cylinders that rotate in opposite directions. For the 
present system, the angular velocity of the outer cylinder is “0” and therefore the 
transition of the flow pattern is solely dependent on the rotation speed of the inner 
cylinder (Figure 6- red line). The laminar Couette flow changes to other flow regimes 
already at relatively low velocities of the inner cylinder. This is the major drawback of 
the employed system but was omitted by a very thin gap between both cylinders. The 
calculations presented before have been done for infinite cylinders. For finite 
cylinders, effects at the boundary have to be considered as they might also influence 
the flow. However, this effect is limited to the boundary regions only and can be 
neglected above a sufficient length of the cylinders. 
In the employed circular system, cells were exposed to shear stress at the inside of 
the outer cylinder. The wall shear stress for the system was calculated using a 
derivation of the Navier-Stokes equation (eq.4). As the outer cylinder is static, its 
angular velocity equals zero and therefore the equation was further simplified to 
(eq.5).  
 
      
   
      
    
   
    
  
                                    (eq.4) 
 
 
      
   
    
   
    
  
                                              (eq.5) 
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1.2.3 Other shear stress devices 
 
In research on shear stress, devices other than the Taylor-Couette systems have 
been used in the past. Usually, the parallel plate flow chamber is one of the most 
frequent systems employed. However, there are negative aspects of this system 
which forced researchers to find alternatives for the flow chamber concept. Firstly, 
the chamber has to be very thin and long, and secondly, the flow is mostly generated 
by pulsatile pumps and therefore flow rate and pulse frequency are connected to 
each other. Two of the most promising alternative systems are presented below. 
First, the rotating plate and cone-based system, and second, a setup comprising 
tissue-engineered vessels for shear stress simulation. 
 
1.2.3.1 Parallel plate flow chamber-based device  
 
The parallel plate flow chamber can been used for shear stress experiment with cells 
[90]. Laminar shear stress develops within the chamber when fluid flows between the 
fixed plates (Figure 7).   
 
Figure 7 Schematic view of a parallel flow chamber (saggital cross-section). 
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The shear stress in the chamber can be calculated using (eq.6). (Q) is the volumetric 
flow rate, (µ) is the dynamic viscosity, (b) is the width of the chamber and (h) is the 
height of the chamber.   
 
    
   
    
                                             (eq.6) 
 
1.2.3.2 Rotating cone and plate-based device 
 
Similar to the Taylor-Couette system, this device is also deducted from former 
rheological measurement purposes. A cone on top of the system rotates, while the 
plate at the bottom is fixed (Figure 8). The gap between both surfaces is filled with 
medium. In the bottom plate, slides covered with cells can be mounted. 
 
Figure 8 Schematic drawing of a rotating cone and plate device for shear stress 
testing. Cells can be seeded on slides (green) embedded in the fixed bottom plate. 
Due to the angle between rotating cone and surface, uniform shear stress is 
generated across the total bottom area (yellow). 
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The distance (d) between the cone and the plate increases with increasing radius (r). 
Thus, when the cone rotates, identical shear stress is generated uniformly on the 
whole surface. This is due to the cone architecture with a defined angle (α). In 
systems that are based two parallel rotating plates, a major drawback is that with 
increasing distance from the middle, the angular velocity (ω), and with it the shear 
stress (τ), changes. Consequently, a shear stress gradient is generated [75]. Shear 
stress for parallel plate devices can be calculated with (eq.7). Cone and plate shear 
stress level is determined by (eq.8). 
 
 
 
     
 
 
                                    (eq.7) 
 
 
 
                                   
 
 
                                     (eq.8) 
 
 
 
Similar systems based on the cone and plate principle were successfully used to 
investigate influence of shear stress on ECs [91-93]. Nonetheless, there are also 
several weaknesses with cone and plate-based systems. Firstly, the angle (α) has to 
be very small in order to prevent the premature onset of turbulence. Secondly, these 
systems have an enormous evaporation rate and need to be refilled with fresh 
medium frequently [94].  
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1.2.3.3 Tissue-engineered vessel-based device 
 
A tissue-engineered vessel cultured with cells of interest on its luminal surface is 
connected to a flow circuit to that is driven by a peristaltic pump. By fluid flow, the 
shear stress is generated in the tissue-engineered vessel. The system can be 
compared to a pipe (Figure 9), which is why shear stress calculation can be 
performed using (eq.9). At present, there have only been a few attempts where this 
shear stress device has been employed. This is reasonable considering the 
enormous efforts that are necessary to generate a suitable tissue-engineered vessel. 
It is a time-consuming process combined with high costs. The approach with artificial 
vessels is also complicated to realize [77, 78]. 
 
 
Figure 9 Schematic view of a pipe.  
 
                                  
 
   
                                     (eq.9) 
 
This introduction served to provide a synopsis on current knowledge about ECs and 
their progenitors, the EPCs. It described in detail the mobilization of EPCs from the 
bone marrow and dealt with relevant clinical applications for these progenitors to 
highlight their importance.  
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1.3 Aim of this study 
 
In the introduction, advances and limits of shear stress research on EPCs were 
outlined by discussion of relevant publications in this field. Finally, frequently used 
shear stress devices were briefly described and evaluated. The aim of the current 
study was to address the aforementioned issues on EPCs yet from another angle. In 
the blood circulation not only laminar flow patterns are present. Within small vessels 
and capillaries steady laminar flow is prevalent. Large arteries, on the other hand, 
exhibit a more pulsatile flow that becomes even turbulent at branching points and 
bifurcations of the vasculature. In addition, turbulences can develop at atherosclerotic 
plaques and at sutures of transplanted conduits as well.  Consequently, it is important 
to monitor these entire conditions to get a complete overview of the EPC response to 
shear stress, which was the major objective of this study.   
In order to examine these diverse flow conditions of the native EPC environment, two 
different devices have been employed in the current study. A custom made flow 
chamber was used to examine effects of pulsatile flow patterns on EPCs while a 
novel device was used for the respective shear stress experiments with laminar and 
turbulent flow conditions. Based on Taylor-Couette flow, this new device lacks most 
of the problems described for apparatuses that are currently in use. Detailed 
information can be found at the respective chapter. One major advantage of the 
Taylor-Couette system is that it not only provides well defined laminar flow conditions 
but also turbulence if desired.  
The expression levels of four flow sensory proteins (eNOS, vWF, PECAM-1 and 
VEGFR-2) were examined by comparative real-time PCR to assess the shear stress 
response of EPCs. The current study focused in particular on PECAM-1and VEGFR-
2 as it has already been shown in literature that they form a shear stress responsive 
complex. Therefore real-time PCR data for these proteins was supplemented by in 
situ immunofluorescent staining with the respective antibodies. In contrast to the 
commonly used flow cytometry examination, no detachment of the cells was 
necessary for the applied procedure. By these means possible changes in protein 
expression caused by the detachment process of the cells were avoided. This is very 
important considering that both proteins are mechanosensory.  
An additional objective of this study was to investigate if the applied shear stress 
conditions permit “homing” of EPCs. Homing, a process rather known from 
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leucocytes, can be described as attachment of cells from the blood circulation to the 
vessel wall. This mechanism is currently discussed as an initial step for the EPC 
based vascular repair. Hence, EPC containing cell suspensions were exposed to 
various flow conditions and their homing potential was estimated.  
The mechanism by that EPCs heal injured vessel sides after their homing is not 
entirely understood yet. However, one key aspect of this process seems to be their 
potential to differentiate into an endothelial like cell type. Comprising this ability, 
EPCs could become a suitable cell source for “Tissue Engineering”, an important and 
rapidly developing field in medical research. The BioStent is a tissue engineered 
stent construct that comprises an inner layer of autologous endothelial cells. 
Regrettably, biopsy is still inevitable for the cell harvest. Therefore other cell sources 
for endothelial cells have to be established. EPCs can differentiate into the 
endothelial phenotype and they can be easily isolated from blood. Succinctly, they 
appear to be a well-suited substitute for endothelial cells. Therefore, in the current 
study EPCs were compared with endothelial cells. Immunfluorescent methods and 
SEM images revealed surprising results that are reported under the particular 
chapter. 
At last, the current Taylor-Couette system was very valuable for studies on EPCs. 
However, in its present version the device did not entirely exploit the huge potential of 
Taylor-Couette based systems. Therefore, the technical progression of Taylor-
Couette system was pursuit in parallel to the studies on EPCs. Details on this topic, 
like the addition of pulsatility to the system, will be discussed in further chapters.  
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2. Materials and Methods 
 
To investigate the impact of different flow conditions on EPCs, this cell type was 
isolated from human venous blood. Two different devices were used for the 
experiments: a novel Taylor-Couette-based system permitting the generation of 
defined laminar and turbulent flow, and a parallel plate flow chamber providing 
pulsatile flow with defined laminar shear stress rates.  
Attachment of very early EPCs from the mononuclear cell fraction was investigated in 
homing experiments. In addition, late outgrowth EPCs were exposed to shear stress 
and their phenotype was examined by means of comparative real-time PCR, immune 
fluorescent stains and functional assays for nitrogen oxide production to determine 
their response to shear stress. Finally, early outgrowth EPCs were used to 
endothelialize the tissue-engineered "BioStent" with the aim to evaluate their 
feasibility for this purpose.  
 
2.1 Materials (Please see appendix) 
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2.2 Methods 
 
2.2.1 Isolation of EPCs 
 
This is a protocol for isolation of EPCs from human peripheral (venous) blood. It is 
based on the selection of adherent cells on fibronectin-coated surfaces. This method 
is more cost effective than the commercially available magnetic bead-based method 
and yields sufficient EPCs.  
 
Before the isolation process, culture flasks must be coated with fibronectin.  
Coating flasks with fibronectin 
1) Dissolve 1 mg of fibronectin in 5 ml of sterile H2O (1.5 h at RT) to a concentration 
of 200 µg/ml. 
2) Sterilize this solution by driving it through a 0.25 µm sterile filter and prepare 
aliquots of 250 µl. Store at -20°C. 
3) Before coating, the fibronectin solution has to be adjusted with sterile PBS 
(phosphate-buffered saline) diluting the aliquots in a ratio of 1:20 to the final 
concentration of 10 µg/ml. 
4) Subsequently, this fibronectin solution is filled into sterile cell culture flasks until 
their entire surface is covered equally with liquid. (T75 flask ~ 4 ml, T25 flask ~ 2 ml, 
LumoxTM Slide flask ~ 1.5 ml) 
5) After incubation for 2 h at 37°C in a humidified incubator with 5% CO2, the 
fibronectin solution is withdrawn and disposed. 
6) The surface of the cell culture vessel is now coated with fibronectin and ready to 
use for cell seeding.  
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Isolation of EPCs 
1) A sterile solution with Dextran (6%) is prepared in PBS and mixed in 1:1 ratio with 
trisodium citrate (3.13 %).  
2) 5 ml of this anticoagulant mixture are filled into a 50 ml syringe. 
3) 45 ml of human peripheral blood are aspirated into the prepared syringe and 
mixed with the anticoagulant by carefully inverting 3 times.   
4) The syringe is then placed in the upright position and allowed to rest for 1/2 h at 
RT under the sterile hood until two different layers emerge. Erythrocytes form the 
bottom layer and are covered by a layer of mononuclear cells. 
5) The mononuclear cell layer is subsequently placed carefully onto 17.5 ml BiocollTM 
separating solution (1.077 g/ml) in a 50 ml falcon tube. Due to the different density of 
the two cell populations, they can be separated in this manner. 
6) This falcon tube is then centrifuged at 400 x g for 15 min. Important: to preserve 
the separated layers, the brake of the centrifuge must be turned off. If possible, also 
choose a slow acceleration rate.  
7) After centrifugation, four layers appear. On top, there is blood plasma, and below 
this is the buffy coat containing mononuclear cells. Under the buffy coat is the 
BiocollTM separating solution and below this are the residual erythrocytes.  
8) The blood plasma layer is carefully removed until only 2 ml above the buffy coat 
are left.  
9) With a 10 ml pipette, the buffy coat layer is aspirated (including approximately 2 ml 
of the separating solution below and 2 ml of blood plasma above) and transferred 
into a 50 ml falcon tube containing 25 ml of sterile PBS. The buffy coat of 2 syringes 
can be placed into this falcon tube, if needed.  
10) The volume is then filled up to 50 ml with sterile PBS and centrifuged at 300 x g 
for 5 mins. After centrifugation, a visible white pellet of cells emerges at the bottom of 
the falcon tube. 
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11) All liquid is now removed. The cell pellet is resuspended by first flipping the base 
of the falcon tube. Then, 50 ml of sterile PBS are added and cells are washed by 
inverting the falcon tube 5 times.  
12) A centrifugation step at 200 x g for 5 min follows this procedure. Again, a cell 
pellet can be observed at the base of the tube. Repeat step 11). 
13) Now estimate the total cell number by counting in a Neubauer chamber and 
centrifuge again at 200 x g. 
14) Remove all liquid. Flip the falcon tube to resuspend the cells and adjust the cell 
concentration by adding the required volume of medium for your experiment. 
Example: 2 x107 cells per LumoxTM slide flask. 
15) Incubate at 37°C and 5% CO2 in a humidified incubator and follow instructions on 
cultivation of EPCs from 2.2.2. 
 
2.2.2 Cultivation of EPCs 
 
Three days after the isolation of mononuclear cells from blood, the complete 
supernatants containing non-attached cells are removed. Then, the surface is 
washed carefully with sterile PBS. Finally, medium has to be added to the cells again 
and they are incubated at 37°C and 5% CO2 in a humidified incubator.  
Cells are required to be fed every three days. Depending on the desired cell type, 
culture duration varies. 
Very early EPCs can be found in the mononuclear cell fraction and were used without 
pre-cultivation in homing experiments to mimic the native conditions as accurately as 
possible. 
For early EPCs, cell culture is completed after 7 days. Cells are then detached with 
accutase and used for experiments. 
Late outgrowth EPCs on the other hand require 18 days of cell culture until they 
assume their final phenotype.  
45 
 
 
2.2.3 Flow cytometry analysis of EPC 
 
Flow cytometry was performed on a BD FACSCaliburTM (BD Biosciences, 
Heidelberg, Germany) flow cytometer according to the following protocol. 
Before starting the experiment, the following tips should be regarded:  
a) Before buying antibodies for flow cytometry, the instrumentation has to be checked 
- what lasers and filters are available?  
b) Can the antibodies of choice be used in a double or triple staining experiment 
without enormous trouble with compensation?  
c) Fluorescently-labelled antibodies are sensitive to temperature and light. 
d) A high cell number is necessary for reliable measurements. The same number of 
cells is also needed for the isotype control. 
e) Permeabilization of the cell membrane is necessary for staining of cytosol resident 
proteins.  
Cell staining for flow cytometry  
1) Cells are detached with Accutase in order to preserve the epitopes on the cell 
surface. 
2) Cells are centrifuged at 500 x g for 2 min. 
3) The cell pellet is loosened by flipping and resuspending in 5 ml of sterile PBS to 
wash the cells.  
4) Cells are centrifuged at 500 x g for 2 min. 
5) The cell pellet is loosened by flipping, resuspended in 1.5 ml sterile PBS and 
transferred to a sterile 1.5 ml Eppendorf reaction tube. 
6) The reaction tube is centrifuged at 500 x g for 2 min. 
7) The cell pellet is loosened by flipping. 
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8) In order to stain cells for a flow cytometry measurement, 10 µl of directly labelled 
antibody is added to the cell suspension and mixed by pipetting up and down.    
9) In parallel 10 µl of the isotype control antibody is given to cells of the same 
population in a separate reaction tube and also mixed by pipetting. 
10) Incubate at 4°C for 30 mins in the dark. 
11) After incubation cells are resuspended in 1 ml of sterile PBS.  
12) The reaction tube is centrifuged at 500 x g for 2 min.  
13) After centrifugation, cells are loosened by flipping and resuspended in 1 ml  of 
sterile PBS. 
14) Repeat: 12) & 13) three times. 
15) After the last centrifugation step, loosen the cell pellet by flipping and resuspend 
the cells in 700 µl of PBS.  
16) Transfer the cells to a flow cytometer tube for the FACSCaliburTM and measure.  
Measurement with FACS CaliburTM  
In order to measure the protein expression of the cells, they first have to be gated. 
Gating is performed to exclude debris and larger cell aggregates from the 
measurement. In a flow cytometer, cells are driven through a very thin nozzle and 
mixed with carrier buffer, and by this method, cells are separated and the profile of 
every single cell can be determined. The first parameter to be estimated is the 
forward scatter. This value serves to estimate the size of the cell. The second 
parameter is the sideward scatter value that allows determination of the 
granularity/complexity of the cell.  
After the population gate is set according to size and granularity, measurement of the 
protein expression can be performed. The amount of bound antibodies serves to 
quantify the amount of expressed protein on the cell surface. For that reason, the 
fluorescently labelled antibodies are excited with light in a defined wave length. Then, 
the emission level is detected and the sum of protein is correlated with the signal 
strength.  
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2.2.4 Staining of cells with DiI - labelled acetylated low density lipoprotein (DiI 
ac-LDL) 
 
Ac-LDL can be coupled to a fluorescent dye such as DiI ( l,r-dioctadecyl-l-3,3,3',3'-
tetramethyl-indo-carbocyanine perchlorate) [95]. Endothelial cells have scavenger 
receptors and can selectively take up acetylated low density lipoprotein. By this 
method, ECs can be distinguished from other cells e.g. fibroblasts [96, 97]. DiI 
labelled ac-LDL is still used as a standard marker for EPCs as well [98]. 
Staining protocol for DiI ac-LDL 
1) Wash cells with PBS.  
2) Add 10 µg/ml DiI-ac-LDL to the cells and incubate for at least 4 h at 37°C and 5%                                        
     CO2 in a humidified atmosphere. 
3) Wash cells with PBS and analyze with fluorescence microscope immediately.  
 
2.2.5 Staining with FITC labelled UEA - lectin 
 
It has been previously demonstrated that isolated human umbilical vein endothelial 
cells bind UEA-lectin. Fibroblasts on the other hand were not able to bind this 
chemical compound [15]. UEA-lectin could be therefore used as endothelial cell 
marker. Of interest, UEA-lectin is also used for staining of EPCs [98]. Commercially 
available UEA-lectin is typically bound to the fluorophore FITC and can be thus 
detected with a fluorescence microscope. 
Protocol for EPC staining with FITC - labelled UEA-lectin 
1) Wash cell with PBS. 
2) Fix cells with methanol at -20°C for 10 min. 
3) Wash with PBS. 
3) Add PBS with 3% BSA (bovine serum albumin) for blocking and incubate at 4°C 
for 10 min.  
4) Remove blocking solution. 
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5) Dilute UEA-Lectin stock in 1:100 ratio in PBS and add to the cells. 
6) Incubate at 37°C for 1/2 h. 
7) Wash with PBS. 
8) Evaluate cells with microscope. 
 
2.2.6 Isolation of HUVECs (human umbilical vein endothelial cells)   
 
Steps before isolation: 
a) Cell culture flasks have to be coated with gelatin (2%) to ensure optimal growth 
conditions for endothelial cells.  
b) PBS, medium and collagenase must be warmed to 37°C. 
Isolation: 
1) Human umbilical cord is obtained from the hospital with permission of the local 
medical ethics committee 
2) Human umbilical cord usually has two arteries and one larger vein. Cannulae are 
placed into the vein from both sides and fixed. 
3) 50 ml of sterile PBS are then flushed to wash the vein and to ensure that there is 
no leakage at the fittings and no blood clots within the vessel. 
4) 10 ml of collagenase are thereafter flushed into the vein and kept within for 
incubation (1/2 h at 37°C and 5 % CO2) in order to detach ECs from the vessel wall. 
5)  After incubation, the contents of the vein are emptied into a 50 ml falcon tube.  
6) Residual cells are flushed out of the vessel with 20 ml sterile PBS into the same 
falcon tube. (Avoid dispersing of the cord as this might release fibroblasts from the 
vessel and contaminate the endothelial cells.) 
8) Centrifuge the falcon tube at 400 x g for 5 min. 
49 
 
9) Dispose the supernatants and resuspend the cell pellet in endothelial cell medium 
(EBM-2, Lonza, Basel, Switzerland) 
10) Transfer this suspension into the gelatin-coated cell culture flasks.  
11) The arteries from the umbilical cord are needed for myofibroblast isolation and 
should therefore not be disposed yet (myofibroblast isolation see 2.2.8).  
 
2.2.7 Cultivation of HUVECs 
 
HUVECs from the isolation are in passage 0 (P0) and low in count. In order to get 
enough cells for experiments, they need to be cultivated. Therefore, cells are fed two 
times a week with fresh medium. When cells in P0 grow to 70% confluence of the T75 
cell culture flask, they ought to be dispersed onto more growth space.  
 
Passaging of cells: 
Before starting to passage cells, the required number of T75 flask has to be prepared 
by coating with gelatin (2%). Medium, PBS (calcium and magnesium free), and 
trypsin/EDTA solution must be heated to 37°C.  
1) At 70% confluence, cells are checked for contamination.  
2) Cells are then washed once with sterile PBS to remove residual proteins from the 
medium. 
3) 3 ml of trypsin/EDTA are added to the cells and incubated for 5 min at 37°C and 5 
% CO2 in a humidified atmosphere.  
(Trypsin is a serine protease that specifically cuts at the carboxyl side of lysine or 
arginine in case they are not followed by a proline residue. EDTA binds calcium 
cations and helps to release cadherin-based cell bonds.) 
4) 6 ml medium is added to inactivate the trypsin. (At this point cell number can be 
assessed.) 
5) Cells are transferred into a 50 ml falcon tube and centrifuged at 400 x g for 5 min. 
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6) Supernatants are removed and the falcon is flipped to loosen the cells. 
7) Cells are resuspended in 20 ml medium and distributed into the prepared T75 
flasks. (Cells are now split at a ratio of 1:2; in later passages ratios of 1:3 are more 
common).  
8) Cells are now in passage P1. When they reach 70% confluence, they can be split 
again. This is repeated until the desired number of cells is reached. 
 
2.2.8. Isolation of myofibroblasts from umbilical cord arteries 
 
1) Umbilical cord connective tissue is carefully removed from the arteries.  
2) Residual blood and clots are flushed out of the arteries and are disposed. 
3) Arteries are cut into small rings (~1 mm thick) and placed in a T75 flask.  
4) Rings are equally distributed over the whole area of the flask. During this time, 
they adhere to the surface.  
5) 10 ml of DMEM medium (37°C) are slowly added to the flask.  
 
2.2.9. Cultivation of myofibroblasts 
 
In order to propogate enough cell numbers from the isolated myofibroblasts (2.2.8), 
cells are fed two times per week with fresh DMEM and passaged if necessary.  
1) After 2-3 weeks of cultivation, cells begin to grow out of the artery rings and 
adhere to the base of the flask.  
2) Rings are then carefully removed and disposed. Adherent cells are grown to 70 % 
confluence.  
3) When the cells reach confluence of 70 %, they are passaged (as described in 
2.2.7). 
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2.2.10. Real-time PCR analysis 
 
From DNA to protein 
 
The production of almost all eukaryotic proteins begins in the nucleus of a cell. Here, 
the information for proteins is encoded in the DNA chain. However, not all proteins 
encoded herein are expressed at the same time. They are subjected to regulatory 
mechanisms. Thus, the production of a certain protein can be started when needed. 
If this is the case the chromatin at the respective locus unfolds and makes the DNA 
accessible to the transcription apparatus. By transcription, information from the DNA 
level is namely transcribed in a RNA sequence. As this happens after splicing, only 
information from exons and not introns can be found in this RNA. Hence this RNA is 
called mRNA (messenger RNA) as it serves as a messenger to transfer information 
from the nucleus to the ribosomes in the cytosol. At the ribosomes, mRNA 
information is translated into the amino acid sequence for a certain protein. Thus, the 
level of mRNA can be correlated with the amount of protein molecules. The more 
mRNA that is present, the more protein can be found. However, other factors might 
also play an important role in this context. The stability of the mRNA a crucial factor 
and sometimes used by cells to regulate the protein level. The stability of a protein 
and the accessibility of certain amino acids for its assembly play important roles. 
Therefore, it is sometimes necessary to correlate the data from real-time PCR with 
other methods that can directly detect the protein amount of a cell. This can be 
facilitated with western blots or other antibody-based methods.  
 
Principle of the real-time PCR  
 
Real-time PCR is a method that allows an estimation of the quantity of mRNA for a 
certain protein of interest within a cell or a cell population. In order to estimate the 
amount of mRNA, total RNA from a cell must first be isolated (for RNA isolation 
protocol, please see 2.2.10.1). Then, with aid of the enzyme reverse transcriptase, all 
mRNAs have to be translated into cDNA (complementary DNA), a DNA sequence 
without introns (for cDNA synthesis protocol, see 2.2.10.2). The synthesized cDNA 
52 
 
serves as template in the real-time PCR and is added to the reaction mix in a defined 
concentration. For a real-time PCR analysis, specific primers are also needed.            
A primer is a short nucleic acid sequence that is necessary as a starting point for the 
DNA polymerase. The choice of appropriate primers is crucial for a reliable real-time 
PCR and many factors have to be taken into account to design them (for design 
protocol, see 2.2.10.3). A real-time PCR is performed on a device known as a real-
time PCR cycler. This machine has heat elements that can adjust temperature very 
rapidly and precisely. In addition, it has a built-in fluorescence reader. Different 
working principles are possible with the cycler but all of them are fluorescence-based. 
In this work, a SYBR Green kit was used due to its flexibility. Briefly, SYBR Green is 
an intercalating dye which means it binds to double-stranded DNA. Once bound to 
DNA, the fluorescence of SYBR Green is higher when compared to its unbound 
state. The more double stranded DNA that is produced, the more SYBR Green binds 
resulting in a higher fluorescence signal.  
Initially, a temperature of 95°C for 10 min is applied to the reaction mix to activate the 
hot start DNA polymerase. Hot start polymerases are inactive at low temperature 
because antibodies are bound to their catalytic centre. This is to prevent unspecific 
polymerization at lower temperature and hence diminishes the formation of primer 
dimer (for more information, see primer design protocol 2.2.10.3). At 95°C, the 
antibody is irreversibly denatured and the polymerase becomes active. 
The real-time PCR temperature conditions are then cyclically changed between two 
temperatures, 95°C and 60°C, in order to allow three steps of the PCR reaction 
(Figure 10). These steps are dissociation, annealing and elongation. At 95°C, DNA 
molecules in the reaction mix dissociate and become single stranded, and are 
therefore made available for primer binding. The binding of primers to single strands 
of DNA is called annealing and requires a temperature around 60°C. This 
temperature level is held for 1 min permitting the DNA polymerase to bind to the 
primer and elongate the DNA chain according to the template strand. DNA 
polymerase in this reaction mix is derived from a thermophil organism and can 
withstand the melting temperature of 95°C without being destroyed. Thus, it is reused 
for the next cycles and no additional DNA polymerase has to be added. 
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Figure 10 Typical stages of real-time PCR cycling protocol.  
 
Under optimal conditions, amplification of DNA is exponential. A typical real-time 
PCR run encompasses between 35-45 cycles. At the end of each elongation step 
fluorescence signal is measured and by this method, DNA content in the mixture can 
be estimated in real-time during the run.  
 
Evaluation of a real-time PCR run 
 
The results from a real-time PCR run are the Ct values for the gene of interest. The 
Ct value describes the cycle number at which the fluorescence signal exceeds a 
defined threshold level. Depending on the initial amount of cDNA, the Ct value is 
lower or higher. If more cDNA from a specific mRNA was present in the beginning of 
the PCR reaction, lower Ct values emerge. Less cDNA means higher Ct values. This 
data can be interpreted in two different ways.  
The first way is the quantitative analysis. Here, the Ct value for the gene of interest is 
compared with a dilution series of a gene with known concentration. Then, from the 
dilution series, a standard curve can be calculated. Using this standard curve, the 
absolute RNA concentration for the gene of interest can be estimated. However, this 
method is expensive for high-throughput and becomes unreliable when comparing at 
least two different cell types or conditions from one real-time PCR run. This is due to 
the fact that cells could have been in different physiological states at the time point of 
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RNA isolation. In order to examine two or more populations of cells with each other, 
the comparative real-time PCR method should be applied.   
In the relative analysis method, Ct values form the gene of interest are also 
compared between cell populations. However, these values are normalized before 
comparison with the aid of one or more housekeeping genes. A housekeeping gene 
encodes mRNA for a protein that is required on behalf of maintenance of elementary 
cellular functions. For instance, glyceraldehyde 3-phosphate dehydrogenase 
(GADPH) is an inevitable part of the metabolic glycolysis pathway by which glucose 
is degraded to pyruvate and energy. It has already been shown that this gene can be 
used as housekeeping gene, although it sometimes might be necessary to use a 
panel of more than one housekeeping gene  [99]. Consequently, Ct values of this 
housekeeping gene are estimated in addition to the Ct values for the protein of 
interest. Assuming that amplification for the real-time PCR is exponential and primers 
for both genes work with similar maximal efficiency using the following equations 
(eq.10-13), the fold expression between sample (A) and reference (B) can be 
calculated by the "delta delta Ct method (ΔΔCt) ".  
 
                                                              (eq. 10) 
                                                              (eq. 11) 
 
                                                                 (eq. 12) 
 
                                                                                                        (eq. 13) 
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2.2.10.1. RNA isolation 
 
RNA isolation from cells was performed with the RNeasy© Plus Micro Kit from 
Qiagen (cat.no.:74 034) according to the supplied protocol with some minor 
modifications. 
 
1) Wash cells on the LumoxTM slide with PBS for 5 min. 
2) Add 700 µl RLT Plus lysis buffer to the slide. 
3) Incubate for 1 min. 
4) With a 1000 µl pipette tip, aspirate the lysate and flush the whole slide 2-3 times to 
remove residual cells. 
5.1) To avoid RNA degradation, transfer lysate immediately into a 1.5 ml Eppendorf 
reaction tube and freeze at -80°C for long-term storage. 
5.2) Transfer the lysate to a gDNA Eliminator spin column that is placed in a 2 ml 
collection tube.  
6) Centrifuge at 8,000 x g for 30s. 
7) Discard column and keep the flow-through. 
8) Add 1 volume of 70% ethanol p.a. (~700µl) to the flow-through and mix by 
pipetting up and down.  
9) Transfer 700 µl of this mix from 8) onto a RNeasy MinElute spin column that is 
placed in a 2 ml collection tube.  
10) Centrifuge at 8,000 x g for 15s and discard flow-through. 
11) Repeat steps 9) and 10) with residual 700 µl from 8). 
12) Add 700 µl RW1 buffer on the column. 
13) Centrifuge at 8,000 x g for 15s and discard flow-through. 
14) Add 500 µl RPW buffer on the column. 
15) Centrifuge at 8,000 x g for 15s and discard flow-through. 
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16) Add 500 µl of 80% p.a. 
17) Centrifuge at 8,000 x g for 2 min and discard flow-through and collection tube. 
18) Place the spin column in a new 2 ml collection tube  
19) Dry the membrane centrifuging it at maximum speed for 5 min. 
20) Discard flow-through and collection tube. 
21) Optional: When samples are contaminated with genomic DNA, incubate the RNA 
on the column with DNAse I (InvitrogenTM cat.no.:180 68-015)  for 15 min at RT.  
Repeat steps 16) -20) before proceeding.  
22) In order to elute the RNA from the column, place the spin column in a new 1.5 ml 
tube and add 20 µl RNAse-free water to the centre of the column. 
23) Centrifuge at maximum speed for 1 min. 
24) Discard column. 
25) Estimate the RNA concentration by measuring absorption at a wavelength of 260 
nm using a spectrophotometer (NanoDrop 2000 - Thermo Scientific) and calculate 
the quality by the A 260/280 ratio. The quality of the RNA is good when this value is 
between 1.8-2. 
26) Freeze the RNA at -20°C for long-term storage or use immediately for cDNA 
synthesis.   
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2.2.10.2. Synthesis of cDNA  
 
From the isolated RNA, cDNA for real-time PCR was synthesized using 
SuperScript® VILOTM from InvitrogenTM (cat.no.:117 54-010). For synthesis, the 
supplied protocol was used. 
 
Protocol for cDNA synthesis with SuperScript® VILOTM: 
 
1) For a single reaction add: 
a) 4 µl of 5x VILOTM  
b) 2 µl of 10x SuperScript® enzyme mix  
c)  x µl = 100ng of  RNA Template  
d) Adjust to a total reaction volume of 20 µl with RNAse free DEPC-treated water. 
2) Mix gently and incubate at 25°C for 10 min.  
3) Incubate at 42°C for 60 min. 
4) Stop reaction by incubation at 85°C for 5 min.  
5) Dilute cDNA 1:5 before use in real-time PCR. 
 
2.2.10.3. Primer design 
 
Primers are short nucleic acid sequences necessary for the PCR reaction. During 
PCR cycling, temperature is raised to allow dissociation of DNA strand into two single 
strands. Then, DNA polymerase can synthesize DNA strands complementary to each 
template strand. However, a free 3' - prime end is always needed for initiation of this 
process. Hence, one primer for each strand has to be designed. Once bound, they 
serve as starting point for the polymerization. Below are listed the most important 
rules for primer design. However, it is sometimes tough to respect all rules as the 
sequence of the gene might make this impossible. In this case, a compromise has to 
be found. 
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Rules for a good primer design 
 
1) Length of the primer 
The length of a primer should be in the range of 16-28 oligonucleotides. An optimal 
length for regular real-time PCR application is 18 oligonucleotides. Shorter primers 
have less specificity and complicate the choice of the right annealing temperature. 
Longer primers have a higher tendency for formation of secondary structures.  
 
2)   Primer sequence 
Primers are oligonucleotides and thus consist of bases adenine (A), cytosine (C), 
guanine (G) and thymine (T). Among these four bases, A binds to T and G to C. 
Between A and T are two hydrogen bonds and between C and G there are three 
hydrogen bonds (Figure 11). 
 
 
Figure 11 Pairing of bases in DNA. Adenine pairs with thymine and guanine with 
cytosine. Between A and T are two hydrogen bonds and between C and G there are 
three hydrogen bonds. 
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The number of hydrogen bonds influences the dissociation temperature of bases. 
Two bonds dissociate at lower temperature than three bonds. This is due to the 
higher energy amount that is required to break the additional hydrogen bond apart. 
Melting temperature (Tm) for primers should be in a range between 52-63°C and can 
be approximately estimated by the formula Tm = 2 * (A+T) + 4 * (C+G). High Tm 
values above 65°C should be circumvented to avoid secondary annealing.   C/G 
amount of a primer should lie between 40 % and 60 %.  
Repeated sequences of one base in a row should be particularly avoided as they 
promote the formation of secondary structures. These structures are unwanted in a 
real-time PCR reaction as they lead to the formation of hairpin structures. In the 
hairpin structure, oligonucleotides of the primer pair with the sequence and are no 
longer available for PCR reaction. This reduces the efficacy of the reaction. In 
addition, hairpin structures can appear when primers have complementary 
palindromes within themselves.  Finally, primers should be designed without 
sequences that allow one primer to anneal to the other primer or even to itself 
because this leads to primer dimer formation.  Primer dimers are a by-product that 
competes with the template for DNA polymerase activity and thereby reduces the 
overall efficiency of the reaction. 
The optimal primer binds more effective at the 5' end than at the 3' end. To achieve 
this, a high C/G content in the 5' region should be preferred. A C/G rich 3' region 
should on the other hand be avoided to prevent multiple site annealing. However, the 
very end of the 3' region should be a C or G.  
The template for the PCR reaction is cDNA that derives from mRNA. As a 
consequence, exon / intron boundaries have to be respected for the design process.  
Respecting these rules, the primers listed below were designed and used in real-time 
PCR experiments (Table 3).  
 
 
 
 
 
60 
 
Table 3 - List with primers that were used in this study 
Table 3 Primer list for GADPH, vWF, PECAM-1, eNOS, VEGFR-2, showing the 
sequence, melting temperature (Tm) and C/G content of the respective primer. 
  
 
 
 
2.2.10.4. Real-time PCR setup protocol  
 
Real-time PCR is a very sensitive method and even small pipetting errors can cause 
a high variation between samples. To reduce this effect to a minimum, an electronic 
stepper pipette has to be used. In addition, the number of pipetting steps has to be 
reduced to a minimum. For this reason, the following concept of two master mixes 
was applied. One primer master mix and one template master mix (see pipetting 
protocol below). Finally, the workspace should be treated with UV light before work to 
reduce risk of contamination with foreign DNA. 
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Pipetting protocol for master mixes: 
Primer dilution 1:10 from stock (final concentration of each primer is 10µM) 
 
  Final reaction setup for 1 reaction  
 
   (Always prepare 10% more of all mixes) 
component volume 
POWER SYBR GREEN (2x) 8 µl 
Primer forward + reverse (10µM) 1 µl 
RNAse free MilliQ 6 µl 
cDNA template (dilute stock again 1:5) 1µl 
Total reaction volume 16µl 
 
 
Reaction setup is split into two mastermixes that finally come together in the 96-Well 
plate. This allows better handling of the samples and reduces contamination risk.  
 
Master mix 1 (primer mastermix) 
 
component volume (1x) 
POWER SYBR GREEN (2x) 4 µl 
Primer forward & reverse (10µM) 1 µl 
RNAse free MilliQ 3 µl 
Total reaction volume 8 µl 
 
 
Master mix 2 (cDNA template mastermix) 
 
component volume (1x) 
POWER SYBR GREEN (2x) 4 µl 
cDNA template (dilute stock again 1:5) 1 µl 
RNAse free MilliQ 3 µl 
Total reaction volume 8 µl 
62 
 
 
 
No template control (NTC): 
 
For detection of primer dimer formation, a no template control (NTC) has to be 
performed. The template in the mix is then replaced by RNAse-free MilliQ in NTC.  
The RT minus control serves to check if the isolated RNA is contaminated with DNA. 
Therefore, RNA is placed in the reaction instead of the cDNA template. As it contains 
no DNA, there should be no amplification in this well.  
 
Melting curve analysis: 
 
In order to check for primer dimer formation after the real-time PCR run, a melting run 
has to be performed. The melting temperature is raised gradually at the same time 
the fluorescence signal is measured. Melting temperature (Tm) is specific for each 
DNA sequence and depends on the sequence of the DNA. When the specific Tm for 
the amplicon is reached, strands of the DNA dissociate into single strands and a drop 
in fluorescence intensity can be detected. A reliable real-time PCR should have only 
one peak. Peaks at Tm of primers indicate formation of primer dimers.  
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2.2.11. Immunohistology staining 
 
Immunohistology stains were performed directly on the lumoxTM slides. For this 
reason, slides were removed from the system and immediately subjected to the 
following protocol.  
 
Staining protocol for cells on lumoxTM slides 
 
1) Wash slides with PBS for 5 mins. 
2) Fix cells with methanol at -20°C for 15 mins. 
3) Remove methanol. 
4) Wash with PBS for 5 mins to rehydrate the cells. 
5) Add blocking solution (PBS containing 3 % BSA) and incubate at 4°C for 30 mins.  
6 Dilute primary antibody in 0.5 % BSA containing PBS in a 1:100 ratio.   
7) Add 100 µl primary antibody dilution to the slide and incubate at 37°C for 1 hour in 
a humid atmosphere.  
8) Wash 3 times for 5 mins in excess of PBS to remove unbound primary antibody. 
9) Dilute secondary antibody in 0.5 % BSA containing PBS in a 1:100 ratio.   
10) Add 100 µl secondary antibody dilution to the slide and incubate at 37°C for 1 
hour in a humid atmosphere. 
11) Wash 3 times for 5 mins in excess of PBS to remove unbound secondary 
antibody. 
12) Add two drops of Roti®-Mount FluorCare DAPI mounting solution to fix the 
sample and stain the nuclei of the cells. 
13) Evaluate staining results with a fluorescence microscope (AxioObserver Z1; Carl 
Zeiss GmbH) and the corresponding Software (Axiovision 4.8.2) 
14) Use the same exposure time for all samples. 
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2.2.12. Nitrite oxide measurement 
 
Measurement of NO with Griess reagent 
 
The enzyme eNOS first oxidizes l-arginine to the intermediate product NG-hydroxy-L-
arginine (NOHLA). Finally, in the subsequent oxidation step, l-citrulline is formed and 
nitrogen oxide is released (Figure 12)[100, 101] .  
 
Figure 12 The two step oxidation reaction of l-arginine to l-citrulline is catalysed by 
eNOS and releases nitrogen oxide. First l-arginine is oxidized to NG-hydroxy-L-
arginine (NOHLA). In a second step this intermediate product is further oxidized to l-
citrulline and nitrogen oxide is released.  
 
The released NO is a free radical and has only short half-life. Nitrogen oxide is 
oxidized to nitrite within seconds and then after only a few hours further to nitrate. 
Taking this into account, its detection is difficult. To circumvent this problem, Griess 
assay was used for determination of produced NO. So, nitrogen oxide is not directly 
measured with this assay but the concentration of its oxidation product nitrite is 
detected. Assuming that most of present nitrite and nitrate in samples derives from 
released NO, the amount of nitrite can be linked to the total quantity of NO released 
from cells. The assay is based on formation of a red azodye that can be detected in a 
spectrophotometer at 540 nm wavelength (Figure 13 ).  
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Figure 13 First sulfanilic acid reacts with nitrite to p-sulfanilic cations. Then α-
naphtylamin is added and reacts with these p-sulfanilic cations to form the above 
mentioned red azodye. 
 
First, sulfanilic acid reacts with nitrite generating p-sulfanilic cations. Then, α-
naphtylamin is added and reacts with present p-sulfanilic cations to form the above 
mentioned red azodye. The amount of generated azodye indirectly equals the 
amount of released NO. Samples with high content of NO lead to more azodye 
formation and samples are more reddish. However, as nitrite is transformed into 
nitrate with time, it is important to incubate the samples with nitrate reductase before 
the Griess assay.  Nitrate reductase is an enzyme that catalyses the reaction of 
nitrate to nitrite. This guarantees that all produced NO is entirely enclosed in the 
assay.   
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Protocol for measurement of NO by means of Griess reagent 
 
Shortly before starting the assay, apply NADH and nitrate reductase to all samples to 
assure that all nitrate is transformed to nitrite.  
A) Add 12 µl NADH (2mM) to 100 µl sample volume. 
B) Add 12 mU nitrate reductase to 100 µl sample volume. 
1) Prepare a nitrite standard solution stock (0.1 M). 
2) Dilute this 0.1 M nitrite standard solution in 1:1000 ratio to get a 100 µM working 
solution. 
3) Pre-warm the sulfanilic acid and α-naphtylamin solution to RT. Keep them 
protected from light. 
4) Assign wells in a transparent 96-well plate for standard curve and samples - each 
in at least triplicate
 
Figure 14 Regular setup of a 96-well plate for the Griess based NO assay. Columns 
1-3 are reserved for the standard curve (100 µM - 0µM nitrite). Remaining columns 
are free for samples that should be at least measured in triplicate.   
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5) All wells in columns 1-3 and rows B-H are filled with 50µl of fresh medium (same 
lot that has been used for the experiments). 
6) Wells 1-3 in row A are then filled with 100 µl of 100 µM nitrite standard. 
7) Now, using a multichannel pipette transfer 50 µl from row A (well 1-3)  to row B 
(well 1-3) and mix by pipetting up and down. 
8) Using new pipette tips continue transferring 50 µl from row B (well 1-3) to row C 
(well1-3). 
9) Keep on diluting the standard curve in this way (C > D > E > F > G) until you reach 
row G. 
10) In the last step, remove and dispose 50 µl from the mix in row G. Row H serves 
as medium reference. 
11) Fill 50 µl of sample in triplicate into the well on the sample region of the plate.  
12) Add 50 µl of sulfanilic acid solution to the samples and to all standards and 
incubate for 5-10 mins protected from light. 
13) Add 50 µl of α-naphtylamin solution to the samples and to all standards and 
incubate for 5-10 mins protected from light. 
14) Measure the absorption in all wells with a plate reader at 540 nm wavelength 
immediately after 13). 
15) Use the absorption values from the standards to generate a standard curve.  
16) With the standard curve, NO concentration of the samples can be estimated. 
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2.2.13 Assembly of the Taylor-Couette system  
 
The Taylor-Couette system (Figure 15) used in this work was designed and 
developed by Simone Wirz during her MD thesis study at the RWTH Aachen 
University. It was manufactured in the mechanical workshop of the Helmholtz 
Institute at the RWTH Aachen University. This device circulates fluid in the gap 
between an inner and outer cylinder through rotation of the inner cylinder. By this 
method, defined levels of shear stress can be generated with this system.  
Components of the system 
The system comprises a cylindrical reactor body and a top cover with a chimney 
made from PEEK (Polyether ether ketone), a transparent PMMA (Poly(methyl 
methacrylate)) cylinder with a mould for a magnet, the ceramic ball bearing, slide 
adapters (PEEK), metal clamps and two trimmed lumoxTM slides.  
 
Figure 15 ProE image: Exploded view of the Taylor-Couette system. The system 
comprises a cylindrical reactor body and a top cover with a chimney made from 
PEEK (Polyether ether ketone), a transparent PMMA (Poly(methyl methacrylate)) 
cylinder with a mould for a magnet, the ceramic ball bearing, slide adapters (PEEK), 
metal clamps and two trimmed lumoxTM slides.  
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Assembly of the system: 
 
First, the ball bearing is placed into a hole at the bottom of the reactor body. Then, 
the slide adapters are placed at the sides of the reactor. Thereafter, the PMMA 
cylinder with a magnet inside is placed in the reactor body. An o-ring seal is placed at 
the top cover before it is mounted on top of the reactor with screws. Finally, lumoxTM 
slides are trimmed to the proper size, placed into the reactor body from the sides and 
mounted by metal clamps. Foam silicon sealing is positioned between clamps and 
slides in order to prevent leakage of the system (Figure 16).   
 
 
Figure 16  ProE image: Assembled Taylor-Couette system. Two threads are placed 
in the top cover and one at the tip of the chimney. Luer-lock adapters are mounted to 
all three threads. Three-way cocks are connected to both adapters on the top cover. 
Through each one of those medium can be added. Using both of them medium can 
be exchanged. At the luer-lock adapter on the chimney tip a sterile filter is mounted. 
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Finally, luer-lock adapters are screwed in the top cover and three-way cocks 
mounted to them.  With a syringe, medium is filled through a three-way cock into the 
system until it reaches the end of the chimney. Three-way cocks are locked. Residual 
bubbles are removed from the system and the chimney is ultimately closed with a 
gas filter (Figure 17). Now the system is ready to use and placed on a magnetic 
stirrer that drives the magnet bearing inner cylinder. A temperature sensor (not 
depicted in ProE images) was also added to the final version of the system to permit 
online temperature control.  
 
 
Figure 17 Image of the final version of the Taylor-Couette System showing 
implemented adapters and gas filter. An additional temperature probe (ME 4700, 
Medos AG in Stolberg, Germany) that can be found at the bottom of the chimney was 
added to the final system to permit monitoring of thermal conditions within the 
system.  
 
Monitoring of the cells during a run 
 
Using a T.I.M.M. 400 microscope from the SPI GmbH, it was possible to monitor the 
cells during a run. With software of the system, the capture of movies and images 
was possible.  
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Adjustment of shear stress levels 
 
Geometry of the complete Taylor-Couette system was fixed and for all experiments 
the same. The diameters were 52 mm (50 mm with mounted slides) for the outer 
cylinder and 48 mm for the inner cylinder. Medium viscosity was Newtonian and 
steady at 0.0017 Pa*s (37°C). Therefore, shear stress could be regulated by the 
angular velocity of the inner cylinder. 
 
 Using (eq.5), the appropriate revolutions per minute (rpm) required to generate the 
desired laminar shear stress rates could be calculated. Consequently, 410 rpm were 
set to generate a laminar shear stress of 0.85 Pa. This value lies exactly between the 
shear rates applied in the pulsatile driven parallel flow chamber (0.7 and 1.0 Pa) and 
therefore permits good comparability of data between both systems (see 2.2.14.1 
Exposure to different levels of pulsatile shear stress). 
 
In addition to laminar shear stress, turbulent shear stress was also examined with the 
Taylor-Couette system. For this reason, two different turbulence conditions were 
used, a lower turbulence generated at about 600 rpm and a higher turbulence at 
about 900 rpm. Calculation of a shear stress rate is not possible for turbulent 
conditions. Nevertheless, assuming the higher energy input correlated with faster 
rotation, shear stress at 900 rpm should be higher than at 600 rpm.  
 
 
 
 
 
      
   
    
   
    
  
                                             (eq.5) 
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2.2.13.1 Exposure of cells to laminar shear stress and turbulent flow in the 
Taylor-Couette system 
 
Effects of a laminar shear stress and turbulent flow on peripheral blood-derived late 
outgrowth EPCs were investigated with the Taylor-Couette system. A condition 
similar to small vessel and capillary environment was be monitored. Furthermore, the 
effects of low and high turbulence were examined. Thus, the cells were subjected to 
either laminar shear stress of 0.85 Pa, low or high turbulent flow for 24 h and 
subsequently analyzed by both real-time PCR and immune histological in situ 
staining to assess possible changes in their phenotypes. Sheared cells were also 
compared with statically cultured cells. 
 
2.2.13.2 Short versus long time exposure in the Taylor-Couette system 
 
Human peripheral blood late outgrowth EPCs were subjected to 0.85 Pa, low or high 
turbulence for different time spans. Exposition time for each condition was 3 and 24 
h. After stimulation, phenotypes of the cells were evaluated by real-time PCR and 
immune histological in situ staining and compared to statically cultured cells. 
 
2.2.13.3 Nitrogen oxide production under laminar shear stress and turbulent 
flow 
 
The production of nitrogen oxide (NO) is a very important function of endothelial cells. 
Release of this gas in native vessels has an influence on the constriction of smooth 
muscle cells in the media layer of the vessel wall and can regulate vasodilatation. In 
response to the appropriate shear stress, ECs produce and release NO. Late 
outgrowth EPCs have been reported to possess an endothelial-like cell type, hence 
they express the NO-producing enzyme, eNOS. Thus, under influence of shear 
stress, NO should be produced and released by late outgrowth EPCs. For this 
reason, late outgrowth EPCs were exposed to shear stress of 0.85 Pa, low or high 
turbulence for 3 and 24 h. At the end of each experiment, the amount of NO in the 
medium was measured and compared with medium from statically cultured cells. 
Griess reagent was used for NO measurement of the medium samples (see 2.2.12).  
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2.2.13.4 Homing of EPCs to different surfaces and at different non-pulsatile 
flow conditions  
 
EPCs circulate within blood through the entire vessel system and bind to denuded 
vessel walls. There, they develop an endothelial cell-like phenotype and regenerate 
the endothelium layer.  
The mononuclear cell fraction from 500 ml of human peripheral blood, containing 
about 0.002% EPCs at earliest state, was injected into the Taylor-Couette system 
through the injection ports on the top of the device. During this time, the system was 
running at laminar shear stress of 0.85 Pa, low or high turbulence. LumoxTM slides 
were either blank or coated with fibronectin, gelatin, galectin-3, galectin-8 or BSA to 
allow adhesion of cells from the flowing medium. The experiments were run for 3, 24 
and 72 h. The T.I.M.M. 400 microscope was used to monitor binding of the cells to 
the surface. Additionally, lumoxTM slides were examined with light microscopy to 
verify data after a run.  
2.2.14 Assembly of the parallel plate flow chamber with pulsatile flow pattern 
 
Parallel flow chamber pulsatile flow experiments  
 
With the Taylor-Couette system, it is possible to apply defined laminar shear stress, 
low or high turbulence to cells. However, ECs that cover the inner wall of a native 
vessel are normally exposed to laminar flow which is pulsatile. Hence, in order to 
simulate a native environment, the applied flow on EPCs should be pulsatile. In order 
to examine the influence of pulsatility on the cells of interest, a parallel plate flow 
chamber was used2.  
However, in the context of shear stress research on EPCs, the device was also 
feasible. The advantage was that the system was available and designed to work 
with LumoxTM slides. Thus, compared to the Taylor-Couette system, similar 
conditions with regard to growth and gas supply were present for the cells.  
Assembly of the system  
 
                                            
2  
1 
Master thesis by Maren Dietrich entitled "ENDOXY - Development of a bio functionalised Oxygenator Model by 
Endothelialisation of a Gas-Permeable Membrane" May, 2011. 
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Basically, the system consists of two plates made of poly-methyl-methacrylate 
(PMMA). This material can be sterilized by gas plasma. The sealing membrane is 
made of silicone and can be autoclaved. Pump tubing and screws can also be 
autoclaved. All necessary disposables are already sterile. The use of transparent 
PMMA allows monitoring of the cells during a run. The T.I.M.M. 400 microscope was 
used for this purpose and LEDs (light emitting diodes) were shown to be sufficient as 
a light source.  
Figure 18 ProE image showing components of the ENODXY device. Only parts of the 
chamber are depicted, no tubing is enclosed.  The lid (green) is not used for shear 
stress testing. The oxygen chamber (blue) serves as top plate3.  
 
                                            
3
 Master thesis by Maren Dietrich entitled "ENDOXY - Development of a bio functionalised Oxygenator Model by 
Endothelialisation of a Gas-Permeable Membrane" May, 2011. 
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All components of the chamber can be seen in Figure 18. A LumoxTM slide coated 
with cells is placed in the cavity of the bottom plate. Then, a silicon seal is positioned 
on the border of the slide and the top plate is mounted tightly to the bottom plate. By 
this approach, a flat flow chamber is formed that can be perfused. At both ends of the 
chamber are injection ports for fluid application. Short Heidelberger tubing is 
connected to the injection ports. The other ends of the Heidelberger tubing are 
connected to a pump tubing forming a circuit. For generation of shear stress, the 
chamber and all tubes have to be filled with medium in a manner that no bubbles can 
be detected - this is to avoid foam formation. Pump tubing is then mounted into a six 
valve roller pump head of an Ismatec© pump. In order to create flow within the 
system, and to achieve the desired shear stress rates, rotation velocity of the pump 
head has to be adjusted. Relevant dimensions of the chamber are width (b) = 0.018 
m and height (h) = 0.0008 m. Viscosity of the medium is 0.0017 Pa*s. With these 
parameters, the necessary flow rate can be calculated for a desired shear stress 
level using (eq.6). For shear stress levels of 0.45, 0.7 and 1 Pa, flow rates of 37.0, 
57.6 and 82.3 ml / min were used, respectively.  
 
 
 
    
   
    
                                                    (eq.6) 
 
 
2.2.14.1 Exposure to different levels of pulsatile shear stress 
 
Human peripheral blood late outgrowth EPCs were sheared with pulsatile laminar 
stress of 0.45, 0.7 and 1 Pa for 24 h. After shear stress exposition, cells were 
analyzed by both real-time PCR and immune histological in situ staining to assess 
possible changes in their phenotypes. Results were placed side by side with data 
from the Taylor-Couette system runs. By this method, the influence of pulsatility on 
cells could be examined.   
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2.2.14.2 Short versus long time exposure to pulsatile shear stress 
 
EPCs were subjected to pulsatile shear stress of 0.45, 0.7 and 1 Pa for either 3 or 
24h. Effects of pulsatile flow were assessed by real-time PCR and in situ 
immunohistology. Data were then compared using results from the Taylor-Couette 
system runs and statically cultured controls. 
 
 
2.2.14.3 Nitrogen oxide production under pulsatile shear stress 
 
Nitrogen oxide concentration in the medium samples from pulsatile sheared cells was 
estimated with the use of Griess reagent (see 2.2.12. Nitrite oxide measurement). 
The collected data were compared to results from statically cultured cells and cells 
from the Taylor-Couette system. 
 
 
2.2.14.4 Homing of EPCs to different surfaces under pulsatile conditions 
 
To elaborate the influence of pulsatility on binding of EPCs, shear stresses of 0.45, 
0.7 and 1.0 Pa were also used. Other conditions were similar to those for the Taylor-
Couette system (2.2.13.4 Homing of EPCs to different surfaces and at different non-
pulsatile flow conditions). Cells were added through the three-way cock that connects 
the pump tubing with the short Heidelberger tubing before the system was started. 
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2.2.15 BioStent with EPCs and/or HUVECs  
 
The BioStent - a brief overview 
The BioStent is a tissue-engineered construct intended for application at 
athererosclerotic lesions. The basic idea of the concept is to coat a self-expanding 
nitinol stent with a thin layer of fibrin gel that serves as a growth substrate for 
fibroblasts/myofibroblasts. The nitinol stent provides an initial mechanical stability 
until the cells form a sufficiently stable tissue. Thereafter the nitinol stent becomes 
redundant but there is no need to remove it. 
 
Figure 19 Picture showing a BioStent after cultivation and endothelialisation. The 
nitinol struts are coated by the myofibroblast loaded fibrin gel layer. The inside of the 
stent is lined with HUVECs.  
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Over time, fibrin gel that has poor mechanical stability is transformed by the 
embedded cells into extracellular matrix. Fibroblasts/myofibroblasts can be isolated 
from autologous sources such as the arteries of an umbilical cord and therefore a 
foreign body reaction can be avoided.  
 
However, exposition of extracellular matrix to the blood flow would still lead to 
thrombus formation and repeated occlusion of the vessel. To thwart this, the lumen of 
the BioStent is seeded with autologous ECs (HUVECs). HUVECs can be isolated 
from umbilical cord and form an endothelial layer at the inside of the BioStent.  
 
For more detailed information please refer to the respective study on the BioStent 
[102].  
 
 
Feasibility of EPCs for tissue-engineered constructs 
 
For adults, HUVECs are not available. Hence, an alternative concept using human 
peripheral blood EPCs for lining of the BioStent was investigated in the current study.  
To estimate the feasibility of these progenitor cells for lining of the BioStent, they 
were seeded alone and in co-culture with HUVECs into the BioStent. Moreover, the 
regular BioStent with HUVECs and a BioStent without cells were assembled as 
references. For early EPCs, pooling of cells from different donors was inevitable as 
the amount of EPCs in circulation of one donor is insufficient. 
 
Stent morphology was evaluated by fluorescence (DiI-ac-LDL labelling of EPCs) and 
by SEM (scanning electron microscope) to consider the differences between the 
different stents.    
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2.2.16 Development of a novel pulsatile Taylor-Couette system 
 
 
This chapter describes the development of a pulsatile Taylor-Couette shear stress 
bioreactor system that will serve to overcome limitations of the Taylor-Couette 
system used in the current study4. More detailed information on the system can be 
found in the respective study report5.  
As previously described, there are already several devices available for shear stress 
testing of cells working on different principles (please refer to chapter 1.2.3 for 
details). All of these devices have inherent disadvantages which is why there is still a 
need for novel apparatuses that overcome known shortcomings and provide desired 
flow profiles.  
 
2.2.16.1 System requirements - pulsatile Taylor-Couette shear stress device 
 
The following system requirements catalogue was defined in order to circumscribe a 
system setup that provides required shear stress rates and overcomes 
disadvantages of state of the art apparatuses.  
System requirements 
- Generation of shear stress between 0.4 and 2.0 Pa 
- Steady laminar and pulsatile flow patterns possible with one device 
- Pulsatility independent of shear stress rate 
- Pulsatile flow patterns accurately resembling profiles generated by heart  
  beat in the human vasculature  
- Easy assembly and inoculation 
- Easy and safe medium exchange 
- Suitable for long-term experiments 
- System material biocompatible and easy to sterilize  
- Microscopic analysis of cells possible 
- Sufficient gas exchange 
                                            
4
 Prof. Stefan Jockenhövel (RWTH Aachen) and Prof. Mehdi Behbahani (FH Aachen) have supported 
this project. 
5
 Study report by Dennis Krist and Matthias Moser “Planung und Entwicklung eines Bioreaktors zur 
Erzeugung pulsatilem Scherstress, sowie die Auslegung eines Getriebes für Ismatec® Pumpen”. 2012 
(Institut für Textiltechnik der RWTH Aachen). 
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2.2.16.2 Geometry of the systems 
 
In order to satisfy the needs listed in the system requirements catalogue, a modular 
device was created. The base comprising motor and bearing also serves as system 
mount. Depending on requirements for a specific experiment, one of two available 
modules can be connected to the base.  
Module 1 was designed as Taylor-Couette system with a rotating outer cylinder. This 
system can be used to produce steady laminar shear stress in a range between 0.4 - 
2.0 Pa or pulsatile flow. Taylor-Couette systems with an outer rotating cylinder are 
well suited to generate high shear stress, maintaining a laminar flow pattern. Module 
2 is a Taylor-Couette system where the inner and outer cylinder rotate in one 
direction at the same angular velocity. It was designed for generation of pulsatile flow 
only. More information about the generation of shear stress with different Taylor-
Couette systems can be found in chapter 1.1.2 of the introduction. 
On behalf of flow generation, the cylinders are being accelerated and decelerated 
very rapidly. The fluid in the gap cannot follow these fast changes in direction due to 
its inertia. Hence, pulsatile shear stress can be generated. Pulsatile flow patterns up 
to 80 Hz can be generated with both modules aiming to simulate the regular resting 
pulse rate of a human. 
 
2.2.16.3 Design and assembly of module 1  
 
Both modules were produced from PMMA (Polymethyl meth acrylate), as this 
material has a low density (light weight), is inexpensive and can be easily sterilized 
with plasma. Easy inoculation, satisfying microscopy and gas exchange were 
realized using LumoxTM slides as a cell carrier. A LumoxTM slide flask can be used 
similar to regular cell culture flasks for cultivation of cells. For application with the 
novel Taylor-Couette device, the slide is detached from the flask and placed in the 
system. The LumoxTM foil is both transparent and gas permeable, satisfying 
microscopy and gas supply requirements at the same time. Both modules are 
constructed as closed systems to reduce contamination risk. Further medium 
exchange is simple due to the incorporated sampling ports. Injection can be 
performed with regular syringes as the ports have standardized Luer lock connectors.   
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Assembly of module 1  
 
At the beginning of assembly, the stamp is placed into the system body. Later, it will 
be fixed to the system mount and serves as stator of the system (Figure 20 A, B). 
The stamp is also used for injection and withdrawal of medium. Therefore, it has a 
channel that leads from a high position at its side down to the bottom that rests inside 
the system body. This construction permits flushing of air bubbles when filling the 
system with fluid. This is important since air within the system leads to foam 
formation when working with protein rich fluids such as cell culture medium with FCS 
(foetal calf serum). 
 
 
Figure 20 Pictures show step one for the assembly of module 1. System body (lower 
part) and static stamp (upper part) are combined together (A, B). Later the stamp is 
fixed to the system mount and serves as stator of the system.  Moreover, the stamp 
has a built in channel to permit injection and withdrawal of medium.  
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Once the stamp is in place, the cover is fitted to the system body. There is an o-ring 
seal between the cover and system body. The cover also bears threads for the doors 
(Figure 21 A, B).  
 
 
Figure 21 Pictures show step two for the assembly of module 1 (pulsatile Couette 
system). After putting the stamp into the system body a cover (upper part) is mounted 
on top of the system. The cover has a hole through that the stamp passes. Cover and 
stamp to not have contact to avoid friction.   
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Module 1 offers two positions for truncated LumoxTM slides at the sides of the system 
body. Slides are locked in the system with two aluminium doors (Figure 22 A, B). 
 
Figure 22 Pictures show step three for the assembly of module 1. Seeded LumoxTM 
slides are put into the respective place at both sides of the system and fixed with 
aluminium doors. The aluminium doors are equipped with silicone sealing to avoid 
leakage.   
 
 
 
In order to prevent friction, there is no seal between the stamp and cover (Figure23 
B). Without sealing, the system would be prone to contamination from airborne 
germs. In order to solve this problem, a "sealing" method according to the principle of 
a Petri dish was employed. Therefore, a small cover (Figure 23A) was positioned at 
the stamp to cover the opening between cover and stamp. Hence, the system was 
finally protected against microbial contamination from the environment and at the 
same time additional gas exchange was possible (Figure 23 C). As the small cover 
rests on the stamp, it does not move and hence no fixation is required to keep it in 
place.  
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Figure 23 Pictures show step four for the assembly of module 1 (pulsatile Couette 
system). As there is an open gap between stamp and top cover to avoid friction, the 
system is not encapsulated properly. Hence, to hinder spores or bacteria from getting 
into the system an additional part has to be put onto the stamp at the end of the 
assembly process. This part resembles a simple cover for a Petri dish (A). This setup 
allows enclosing the system sufficiently and at the same time avoids friction between 
stamp and top cover. Moreover, gas exchange is improved on top.    
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Figure 24 ProE image showing the pulsatile Taylor-Couette device with mounted 
module1.  
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2.2.16.3 Design and assembly of module 2  
 
The assembly of module 2 is similar to that of the previous module but can be 
performed in two steps. First, the system cover is mounted on top of the system 
body. Sealing is realized by an o-ring. Furthermore, the cover already includes the 
inner cylinder which reduces the steps during assembly. The inner cylinder has two 
holes ranging through the entire cylinder that provide threads for Luer lock 
connectors at the top. Again, the cover component also provides threads for the 
aluminium doors. Without the need for a stator, this system needs no fixation from 
the top and is just placed on the ball bearing (Figure 25). 
 
 
 
Figure 25 Pictures showing the assembly of module 2. The cover with o-ring sealing 
is mounted to the system body. This cover bears the inner cylinder of the system and 
has two threads for luer lock connectors at its top, providing a possibility to supply 
and remove medium.  
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Drive of the system 
The drive of the pulsatile Taylor-Couette system will be realized by a computer 
controlled AC (alternating current) motor. AC motors work with electrical commutation 
and have therefore less friction. Consequently, less heat loss develops and these 
motors also are very durable.  
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3. Results 
 
3.1 Validation of the EPC phenotype 
 
3.1.1 Validation of the EPC phenotype by DiI-ac-LDL and FITC - UEA 1 stain 
 
The phenotype of isolated and cultured peripheral blood late outgrowth EPCs was 
assessed by staining with DiI-ac-LDL and FITC - UEA 1. Cells did bind FITC-labelled 
UEA-1 (green) and took up DiI-labelled ac-LDL (red), an example of which can be 
found below (Figure 26).  
 
 
Figure 26 EPC phenotyping with FITC-UEA-1 and DiI-ac-LDL. Immunofluorescent 
images of late outgrowth EPCs from human peripheral blood that were stained with 
specific markers. (A) Cells bound FITC-UEA-1 (green colour). (B) Cells took up DiI 
labelled ac-LDL (red colour). (C) DAPI stain of nuclei (blue).  
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3.1.2 Flow cytometry analysis of EPC 
 
Flow cytometry analysis with late outgrowth EPCs was not feasible: detachment of 
cells from LumoxTM slides was poor for both statically cultured and shear stressed 
cells. Only a small amount of the cells detached from the surface when using trypsin / 
EDTA. With Accutase, no cells could be released from the surface. However, in order 
to generate reliable data, all cells should be examined. Thus, flow cytometry was not 
a suited method to characterize statically cultured and shear stressed late outgrowth 
EPCs. Instead, an in situ fluorescence method was used to estimate the phenotype 
of the cells directly on the slide. An additional advantage of this method was that no 
proteins were modified/digested as can be the case with trypsin/EDTA.   
 
3.1.3 Optimal cultivation time for generation of human peripheral blood late 
outgrowth EPC (n=3) 
 
The aim was to determine the optimal cultivation time for growth of late outgrowth 
EPCs. Therefore, cells were isolated and cultivated as previously described (2.2.1 
and 2.2.2). The development was documented with bright field microscopy images 
over 28 days for three different donors. Below is a representative series of images for 
the entire three experiments (Figure 27).  
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Figure 27 Bright field microscopy images from a cultivation of human peripheral blood 
derived late outgrowth EPCs over a period of 28 days (representative for experiments 
with cells from three different donors).  From day 18 on EPCs show the typical 
cobblestone like morphology and form a confluent cell layer.  
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At day 18 of cultivation, cells were confluent and a typical cobblestone-like 
morphology could be observed on the slides. These cells were used as late 
outgrowth EPCs in subsequent experiments.  
 
3.2 Laminar shear stress and turbulence experiments in the Taylor-Couette 
system 
 
It was described in previous chapters of this work how important shear stress is for 
the accurate function of ECs in the vasculature and what influence it can have on 
EPCs. The next chapters display data about the influence of laminar shear stress and 
turbulence on EPCs from human peripheral blood. The current Taylor-Couette flow-
based shear stress device was used for this purpose. It was optimally suited to 
expose EPCs to laminar shear stress and also turbulence. 
 
3.2.1 Short versus long time exposure to laminar shear stress of 0.85 Pa  
 
In the literature, EPCs are often exposed to fluid flow for 24 h aiming to examine their 
behaviour under shear stress conditions. With the goal to reduce this time for 
experiments, the exposure period to shear stress of 24 h was compared to 3 h. After 
shear stress exposure, cells were stained with antibodies directed against VEGFR-2 
(CD309) and PECAM-1 (CD31); this was achieved by staining with the according 
fluorescently-labelled secondary antibody. The fluorescent signal intensity for each 
antibody was linked with the expression level of the respective protein. Each shear 
stress rate was examined at least three times always using cells from different 
donors.  
The following immuofluorescent images were taken from one experiment, but are 
representative for all three experiments. A shear stress of 0.85 Pa lies between 0.7 
and 1.0 Pa and was the maximal laminar shear stress rate, achievable with the 
current Taylor-Couette system. Consequently, this mean value was used to generate 
data that can be compared with results from the pulsatile parallel plate flow chamber 
described in following chapters (4.4.1 and 4.4.2).   
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To guarantee high reliability of the data from immunofluorescent images, staining 
conditions were at all times the same for each sample. In addition, an identical 
exposure time was set in all images. 
 
Figure 28 Immunofluorescence image of PECAM-1 (CD31) stain (green), 
representative for three individual experiments with cells from three individual donors. 
Human peripheral blood late outgrowth EPCs were cultured under static conditions 
(A) or subjected to laminar shear stress of 0.85 Pa for 3 h (B) or 24 h (D), 
respectively. Stain control without primary antibody (C). Stain of nuclei with DAPI 
(blue). Stain conditions for all samples were the same and immunofluorescent 
pictures were always taken at the same exposure time to generate comparable 
results.   
 
The signal for PECAM-1 was present in cells under static cultivation conditions and 
spread out to the borders of the cells (Figure 28 A). After 3 h under laminar shear 
stress of 0.85 Pa, there was less signal intensity and its distribution was restricted to 
a corona around the nuclei (Figure 28 B). However, after 24 h exposure to laminar 
shear stress of 0.85 Pa, the PECAM-1 signal was almost diminished to a level 
comparable with the negative control (Figure 28 C, D).  
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Figure 29 Immunofluorescence image of VEGFR-2 (CD309) stain (red), 
representative for three individual experiments with cells from three individual donors. 
Human peripheral blood late outgrowth EPCs were cultured under static conditions 
(A) or subjected to laminar shear stress of 0.85 Pa for 3 h (B) or 24 h (D), 
respectively. Stain control without primary antibody (C). Stain of nuclei with DAPI 
(blue).  Stain conditions for all samples were the same and immuofluorescent 
pictures were always taken at the same exposure time to generate comparable 
results.   
 
VEGRF-2 expression was present in static cultured cells and became stronger after 3 
h of shear stress treatment at 0.85 Pa (Figure 29 A, B). Moreover, the signal was 
spread over the whole cell while in the statically cultured control it was very spotted 
and restricted to cell borders. Interestingly, the expression for VEGFR-2 was 
markedly reduced after 24 h of laminar shear stress at 0.85 Pa, but not as much as 
the signal for PECAM-1 at the respective exposure time. There was still a 
considerable signal difference between the 24 h sample and negative control (Figure 
29 C, D). In addition, about 50% of the cells compared to static conditions removed 
from the surface after 24 h. 
Furthermore, after exposure to 72 h of shear stress, EPCs did not show any 
difference to EPCs after 24 h of shear stress (data not shown). As a consequence, all 
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subsequent experiments were performed with duration of 24 h to certify that the 
entire effect of the applied shear stress is considered.  
3.2.2 Exposure of EPCs to steady laminar shear stress of 0.85 Pa, low and high 
turbulence in the Taylor-Couette system 
 
Cell morphology (n=3) 
 
In the introduction, it was reported how late outgrowth EPCs elongate themselves 
and align in the direction of flow when they are subjected to shear stress. However, 
these results could not be reproduced with human peripheral blood-derived late 
outgrowth EPCs.  Neither with the Taylor-Couette system, nor with the pulsatile flow 
chamber could this be demonstrated at all. Independent of the flow condition, laminar 
steady flow (0.85 Pa), low/high turbulence or laminar pulsatile flow (0.45 Pa, 0.7 Pa 
or 1.0 Pa), the shape of the cells always remained identical. Hence, the 
morphological modifications were always similar to those presented in the 
representative example below for steady laminar flow of 0.85 Pa (Figure 30). Instead 
of elongating and aligning in the direction of flow, EPCs maintained their rounded 
shape, but flattened themselves in response to diverse shear forces. 
 
 
Figure 30 Pictures taken with the T.I.M.M. - 400 microscope camera showing human 
peripheral blood derived late outgrowth EPCs before (A) and after laminar shear 
stress treatment in the Taylor-Couette system with 0.85 Pa for 24 h (B). The black 
arrow indicates the direction of flow.  
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Protein expression at steady laminar shear stress of 0.85 Pa or turbulence (n=3) 
 
With the following experiments, effects of shear stress on EPCs were explored at 
transcriptional and translational levels. Thus, steady laminar shear stress of 0.85 Pa, 
low and high turbulence were examined with the current Taylor-Couette system. 
Taking into account results from chapter 4.2.1, exposure time of 24 h was chosen for 
all experiments. Each shear stress condition was examined at least three times with 
cells from different donors. The following immuofluorescent images are from one 
experiment, but representative for all three approaches.  
 
Steady laminar shear stress of 0.85 Pa - immunofluorescent analysis (n=3) 
 
Steady laminar shear stress of 0.85 Pa reduced the amount of PECAM-1 within 24 h 
to a level that was comparable to that of the negative control (Figure 31) 
Figure 31 Immunofluorescence image of PECAM1 (CD31) stain (green), 
representative for three individual experiments with cells from three individual donors. 
96 
 
Human peripheral blood late outgrowth EPCs were cultured under static conditions 
(A) or subjected to laminar  shear stress of 0.85 Pa for 24 h (B). Stain control without 
primary antibody (C). Stain of nuclei with DAPI (blue).  Stain conditions for all 
samples were the same and immuofluorescent pictures were always taken at the 
same exposure time to generate comparable results.   
After treatment with steady laminar shear stress at 0.85 Pa for 24 h, the signal for 
VEGFR-2 was also diminished. However, there was still a weak signal around the 
nuclei (Figure 32). These results resemble the data from the previous chapter above 
(4.2.1).  
 
Figure 32 Immunofluorescence image of VEGFR-2 (CD309) stain (red), 
representative for three individual experiments with cells from three individual donors. 
Human peripheral blood late outgrowth EPCs were cultured under static conditions 
(A) or subjected to laminar  shear stress of 0.85 Pa for 24 h (B). Stain control without 
primary antibody (C). Stain of nuclei with DAPI (blue).  Stain conditions for all 
samples were the same and immunofluorescent pictures were always taken at the 
same exposure time to generate comparable results.   
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Steady laminar shear stress of 0.85 Pa - molecular biological analysis (n=3)  
 
Late outgrowth EPCs were cultured statically or conditioned at steady laminar shear 
stress of 0.85 Pa for 24 h. Afterwards, both settings were compared by real-time PCR 
regarding the cells’ expression levels for PECAM-1 and VEGFR-2. In addition, 
expression levels for von Willebrand Factor (vWF) and endothelial nitric oxide 
synthase (eNOS) were also examined.  
 
Figure 33 A comparative real-time PCR was performed comprising RNA from static 
cultured late outgrowth EPCs and late outgrowth EPCs that were subjected to 
laminar shear stress of 0.85 Pa for 24 h.  Relative expression levels for PECAM-1 
(CD31) [green], KDR/VEGFR-2 (CD309) [red], von Willebrand Factor (vWF) [blue] 
and endothelial nitric oxide synthase (eNOS) [black] are shown. Confidence interval 
is 95% (n=3). 
 
After shear stress treatment at 0.85 Pa, expression of PECAM-1 (green) and 
VEGFR-2 (red) dropped to about 50% and 25% of the static level.  Expression of 
vWF (blue) and eNOS (black) was not significantly reduced (Figure 33).  
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Taylor-Couette system, low turbulence - immunofluorescent analysis (n=3) 
 
 
Low turbulence markedly reduced the signal for PECAM-1. Only very few cells 
maintained a weak expression for this protein (Figure 34 B).  
 
Figure 34 Immunofluorescence image of PECAM1 (CD31) stain (green), 
representative for three individual experiments with cells from three individual donors. 
Human peripheral blood late outgrowth EPCs were cultured under static conditions 
(A) or subjected to low turbulence for 24 h (B). Stain control without primary antibody 
(C). Stain of nuclei with DAPI (blue).  Stain conditions for all samples were the same 
and immuofluorescent pictures were always taken at the same exposure time to 
generate comparable results.   
 
The results for VEGFR-2 were similar to those for PECAM-1, but more cells 
demonstrated a positive signal for VEGFR-2 compared to PECAM-1 (Figure 35 B). 
However, the intensity was still very low in these cells.  
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Figure 35 Immunofluorescence image of VEGFR-2 (CD309) stain (red), 
representative for three individual experiments with cells from three individual donors. 
Human peripheral blood late outgrowth EPCs were cultured under static conditions 
(A) or subjected to low turbulence for 24 h (B). Stain control without primary antibody 
(C). Stain of nuclei with DAPI (blue).  Stain conditions for all samples were the same 
and immuofluorescent pictures were always taken at the same exposure time to 
generate comparable results.   
 
Taylor-Couette system, low turbulence - molecular biological analysis (n=3)  
 
Late outgrowth EPCs were cultured statically or conditioned at low turbulence for 
24h. Afterwards, they were compared by real-time PCR regarding their expression 
levels for PECAM-1 and VEGFR-2. In addition, expression levels for von Willebrand 
Factor (vWF) and endothelial nitric oxide synthase (eNOS) were also examined.  
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Figure 36 A comparative real-time PCR was performed comprising RNA from static 
cultured late outgrowth EPCs and late outgrowth EPCs that were subjected to low 
turbulence for 24 h.  Relative expression levels for PECAM-1 (CD31) [green], 
KDR/VEGFR-2 (CD309) [red], von Willebrand Factor (vWF) [blue] and endothelial 
nitric oxide synthase (eNOS) [black] are shown. Confidence interval is 95% (n=3). 
 
After shear stress treatment at low turbulence, expression of PECAM-1 (green) 
dropped to about 25%.Expression levels of vWF (blue), eNOS (black) and VEGFR-2 
(red) were not significantly reduced when compared with the static control (Figure 
36).  
 
Taylor-Couette system high turbulence - immunofluorescent analysis (n=3) 
 
The exposure of EPCs to high turbulence for 24 h reduced PECAM-1 expression. 
However, the results were contrary to those for steady laminar shear stress of 0.85 
Pa or low turbulence. There was still a weak signal present in a number of cells 
(Figure 37 B). 
101 
 
Figure 37 Immunofluorescence image of PECAM1 (CD31) stain (green), 
representative for three individual experiments with cells from three individual donors. 
Human peripheral blood late outgrowth EPCs were cultured under static conditions 
(A) or subjected to high turbulence for 24 h (B). Stain control without primary antibody 
(C). Stain of nuclei with DAPI (blue).  Stain conditions for all samples were the same 
and immunofluorescent pictures were always taken at the same exposure time to 
generate comparable results.   
 
The results for VEGFR-2 were on the one hand comparable to those found at 0.85 
Pa or low turbulence, with only a few cells being positive. On the other hand, the 
signal was not reduced to a thin corona around the nuclei this time but rather spread 
along the entire cell (Figure 38 B).  
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Figure 38 Immunofluorescence image of VEGFR-2 (CD309) stain (red), 
representative for three individual experiments with cells from three individual donors. 
Human peripheral blood late outgrowth EPCs were cultured under static conditions 
(A) or subjected to high turbulence for 24 h (B). Stain control without primary antibody 
(C). Stain of nuclei with DAPI (blue).  Stain conditions for all samples were the same 
and immunofluorescent pictures were always taken at the same exposure time to 
generate comparable results.   
 
Taylor-Couette system, high turbulence - molecular biological analysis (n=3)  
 
Late outgrowth EPCs were cultured statically or conditioned at high turbulence for 
24h. Afterwards, they were compared by real-time PCR regarding their expression 
levels for PECAM-1 and VEGFR-2. In addition, expression levels for von Willebrand 
Factor (vWF) and endothelial nitric oxide synthase (eNOS) were also examined.  
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Figure 39 A comparative real-time PCR was performed comprising RNA from static 
cultured late outgrowth EPCs and late outgrowth EPCs that were subjected to 
laminar shear stress of 1.0 Pa for 24 h.  Relative expression levels for PECAM-1 
(CD31) [green], KDR/VEGFR-2 (CD309) [red], von Willebrand Factor (vWF) [blue] 
and endothelial nitric oxide synthase (eNOS) [black] are shown. Confidence interval 
is 95% (n=3). 
 
After high turbulence treatment, the expression level for PECAM-1 (green), vWF 
(blue) and eNOS (black) dropped to about 25% compared with the static control. 
However, VEGFR-2 (red) levels were not significantly reduced (Figure 39).  
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3.2.3 Nitrogen oxide production at 0.85 Pa, low and high turbulence  
 
In the Taylor-Couette system, nitrogen oxide production was not present at any of the 
tested shear stress conditions after 24 h. As determined by Griess assays, the level 
of nitrogen oxide was comparable with that of untreated medium and statically 
cultured cells. The Griess assays were always proven functional by the preparation of 
a standard curve. Thus, late outgrowth EPCs did not produce nitrogen oxide under 
influence of steady laminar shear stress of 0.85 Pa, low or high turbulence.  
 
3.2.4 Homing of early EPCs under laminar flow conditions  
 
The homing capacity of EPCs was tested with the Taylor-Couette system. Therefore, 
human EPCs isolated from peripheral blood were placed in the system and subjected 
to steady laminar shear stress of 0.85 Pa, low or high turbulence. LumoxTM slides 
were left blank or coated with fibronectin, gelatin, galectin-3, galectin-8 or BSA. 
Experiments were run for 3 h, 24 h or 72 h (each n=3). Cell attachment was 
monitored with a microscope camera (T.I.M.M. - 400 SPI Robots) at a single spot and 
under a bright field microscope at the end of the experiments to examine the whole 
slide area.  
No cell attachment could be observed for any of the above mentioned coatings, 
shear stress conditions or run times. As cell death could be a reason for this, 
suspended EPCs were harvested after each run and seeded on fibronectin-coated 
LumoxTM slides. Cells were still viable after 3 h of shear stress. However, cells 
exposed to 24 h and 72 h of shear stress were no longer viable.  
 
3.3 Pulsatile shear stress experiments with EPCs 
 
Blood is driven in a pulsatile manner through the entire human vasculature. Thus, in 
their native environment, ECs are exposed to pulsatility. Taking this into account, 
steady laminar shear stress or turbulence generated with the Taylor-Couette system 
might be inadequate to stimulate EPCs appropriately. Likewise, pulsatility in 
combination with an adequate shear stress may more accurately approximate the 
native conditions from the vasculature system.  
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3.3.1 Short versus long time exposure to pulsatile shear stress  
 
In order to address the issue of pulsatility, human peripheral blood derived EPCs 
from one donor were not only examined with the Taylor-Couette system under steady 
laminar and turbulent conditions; EPCs from the same isolation were tested with the 
Taylor-Couette system and in parallel examined in a pulsatile system.  
The cells were thereafter examined by immunofluorescence in order to estimate the 
incubation time after which most effects are visible. Images are representative for 
three independent experiments with cells from three individual donors (n=3).  
 
Figure 40 Immunofluorescence image of PECAM-1 (CD31) stain (green), 
representative for three individual experiments with cells from three individual donors. 
Human peripheral blood late outgrowth EPCs were cultured under static conditions 
(A) or subjected to pulsatile shear stress of 0.45 Pa for 3 h (B) or 24 h (D), 
respectively. Stain control without primary antibody (C). Stain of nuclei with DAPI 
(blue). Stain conditions for all samples were the same and immunofluorescent 
pictures were always taken at the same exposure time to generate comparable 
results. 
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The signal for PECAM-1 changes after 3 h pulsatile flow of 0.45 Pa from a spotted 
distribution around the cell borders to a small corona around the nuclei. There is no 
loss of signal intensity at all. After 24 h, the signal is weaker but is otherwise 
distributed across the entire cell body (Figure 40). 
 
Figure 41 Immunofluorescence image of VEGFR-2 (CD390) stain (red), 
representative for three individual experiments with cells from three individual donors. 
Human peripheral blood late outgrowth EPCs were cultured under static conditions 
(A) or subjected to pulsatile shear stress of 0.45 Pa for 3 h (B) or 24 h (D), 
respectively. Stain control without primary antibody (C). Stain of nuclei with DAPI 
(blue). Stain conditions for all samples were the same and immunofluorescent 
pictures were always taken at the same exposure time to generate comparable 
results. 
 
 
VEGFR-2 is distributed in a similar fashion to PECAM-1 at 0.45 Pa with pulsatile 
stimulation after 3 and 24 h (Figure 41).  
Taken into account this data, and to permit comparability with results the Taylor-
Couette system, a stimulation time of 24 h was chosen for further experiments. 
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3.3.2 Exposure to pulsatile flow and shear stress levels 0.45, 0.7 and 1 Pa  
 
Protein expression at pulsatile flow and shear stress levels 0.45, 0.7 and 1 Pa (n=3) 
 
In the following experiments, EPCs were isolated from human peripheral blood and 
exposed for 24 h to pulsatile shear stress of 0.45, 0.7 and 1.0 Pa. Thereafter, they 
were examined by immunfluorescent and molecular biological methods and the data 
were compared to values from statically cultured cells. This was to demonstrate any 
changes in transcription and translation for the proteins of interest (PECAM-1, 
VEGFR-2, vWF and eNOS). 
 
Pulsatile laminar shear stress of 0.45 Pa - immunofluorescent analysis (n=3) 
 
PECAM-1 expression became weaker after EPCs were subjected to a pulsatile flow 
of 0.45 Pa for 24 h. Most cells had a positive signal, but there were also some cells 
without. Those with signal had a uniform signal distribution across the whole cell 
shape (Figure 42). The signal distribution was similar for VEGFR-2 (Figure 43). 
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Figure 42 Immunofluorescence image of PECAM1 (CD31) stain (green), 
representative for three individual experiments with cells from three individual donors. 
Human peripheral blood late outgrowth EPCs were cultured under static conditions 
(A) or subjected to pulsatile shear stress of 0.45 Pa for 24 h (B). Stain control without 
primary antibody (C). Stain of nuclei with DAPI (blue).  Stain conditions for all 
samples were the same and immuofluorescent pictures were always taken at the 
same exposure time to generate comparable results.  
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Figure 43 Immunofluorescence image of VERGFR-2 (CD309) stain (green), 
representative for three individual experiments with cells from three individual donors. 
Human peripheral blood late outgrowth EPCs were cultured under static conditions 
(A) or subjected to pulsatile shear stress of 0.45 Pa for 24 h (B). Stain control without 
primary antibody (C). Stain of nuclei with DAPI (blue).  Stain conditions for all 
samples were the same and immunofluorescent pictures were always taken at the 
same exposure time to generate comparable results.   
 
 
Pulsatile laminar shear stress of 0.45 Pa - molecular biological analysis (n=3) 
Late outgrowth EPCs were cultured statically or conditioned at a pulsatile shear 
stress of 0.45 Pa for 24 h. Afterwards, they were compared by real-time PCR 
regarding their expression levels for PECAM-1 and VEGFR-2. In addition, expression 
levels for von Willebrand Factor (vWF) and endothelial nitric oxide synthase (eNOS) 
were also examined.  
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Figure 44 A comparative real-time PCR was performed comprising RNA from static 
cultured late outgrowth EPCs and late outgrowth EPCs that were subjected to 
pulsatile shear stress of 0.45 Pa for 24 h.  Relative expression levels for PECAM-1 
(CD31) [green], KDR/VEGFR-2 (CD309) [red], von Willebrand Factor (vWF) [blue] 
and endothelial nitric oxide synthase (eNOS) [black] are shown. Confidence interval 
is 95% (n=3).  
 
Pulsatile shear stress of 0.45 Pa led to an elevated expression for PECAM-1 (green) 
of about 125 % and for vWF (blue) about 200%. No significant differences in VEGFR-
2 (red) and eNOS (black) could be observed (Figure 44).   
 
Pulsatile laminar shear stress of 0.7 Pa - immunofluorescent analysis (n=3) 
 
A pulsatile shear stress rate of 0.7 Pa for 24 h, on the other hand, had diverse 
influence on PECAM-1 expression compared to that of VEGFR-2. However, under 
these shear stress conditions, the cells had formed clusters.  
The PECAM-1 signal was not remarkably reduced nor were the cells expressing it 
significantly fewer. However, after shear stress conditioning, the signal was spread all 
over the cell with equal intensity, but under static conditions, intensity was highest at 
the borders of the cells (Figure 45). 
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Figure 45 Immunofluorescence image of PECAM1 (CD31) stain (green), 
representative for three individual experiments with cells from three individual donors. 
Human peripheral blood late outgrowth EPCs were cultured under static conditions 
(A) or subjected to pulsatile shear stress of 0.7 Pa for 24 h (B). Stain control without 
primary antibody (C). Stain of nuclei with DAPI (blue).  Stain conditions for all 
samples were the same and immuofluorescent pictures were always taken at the 
same exposure time to generate comparable results.   
 
The signal for VEGFR-2 was considerably reduced after pulsatile shear stress of 0.7 
Pa for 24 h (Figure 46).  
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Figure 46 Immunofluorescence image of VERGFR-2 (CD309) stain (green), 
representative for three individual experiments with cells from three individual donors. 
Human peripheral blood late outgrowth EPCs were cultured under static conditions 
(A) or subjected to pulsatile shear stress of 0.7 Pa for 24 h (B). Stain control without 
primary antibody (C). Stain of nuclei with DAPI (blue).  Stain conditions for all 
samples were the same and immunofluorescent pictures were always taken at the 
same exposure time to generate comparable results.   
 
Late outgrowth EPCs were cultured statically or conditioned at pulsatile shear stress 
of 0.7 Pa for 24 h. Afterwards, they were compared by real-time PCR regarding their 
expression levels for PECAM-1 and VEGFR-2. In addition, expression levels for von 
Willebrand Factor (vWF) and endothelial nitric oxide synthase (eNOS) were also 
examined.  
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Figure 47 A comparative real-time PCR was performed comprising RNA from static 
cultured late outgrowth EPCs and late outgrowth EPCs that were subjected to 
pulsatile shear stress of 0.7 Pa for 24 h.  Relative expression levels for PECAM-1 
(CD31) [green], KDR/VEGFR-2 (CD309) [red], von Willebrand Factor (vWF) [blue] 
and endothelial nitric oxide synthase (eNOS) [black] are shown. Confidence interval 
is 95% (n=3). 
 
Pulsatile laminar shear stress of 0.7 Pa - molecular biological analysis (n=3) 
 
Pulsatile shear stress of 0.7 Pa led to reduced expression of VEGFR-2 (red) to 
approx.10% and elevated expression of vWF (blue) to approx. 250%. PECAM-1 
(green) and eNOS (black) expression showed no significant differences.  
 
Pulsatile laminar shear stress of 1.0 Pa - immunofluorescent analysis (n=3) 
 
Pulsatile shear stress of 1.0 Pa for 24 h had massive impact on the expression of 
both proteins. The signal for PECAM-1 was reduced in overall intensity. In addition, 
the signal was restricted to a small corona around the nuclei (Figure 48).  
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Figure 48 Immunofluorescence image of PECAM1 (CD31) stain (green), 
representative for three individual experiments with cells from three individual donors. 
Human peripheral blood late outgrowth EPCs were cultured under static conditions 
(A) or subjected to pulsatile shear stress of 1.0 Pa for 24 h (B). Stain control without 
primary antibody (C). Stain of nuclei with DAPI (blue).  Stain conditions for all 
samples were the same and immuofluorescent pictures were always taken at the 
same exposure time to generate comparable results.   
 
Through pulsatile shear stress treatment at 1.0 Pa for 24 h, the signal for VEGFR-2 
was even more reduced than that for PECAM-1. Similar to the PECAM-1 signal, the 
signal for VEGFR-2 was only visible in a thin radiance around the nuclei (Figure 49).  
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Figure 49 Immunofluorescence image of VERGFR-2 (CD309) stain (green), 
representative for three individual experiments with cells from three individual donors. 
Human peripheral blood late outgrowth EPCs were cultured under static conditions 
(A) or subjected to pulsatile shear stress of 1.0 Pa for 24 h (B). Stain control without 
primary antibody (C). Stain of nuclei with DAPI (blue).  Stain conditions for all 
samples were the same and immunofluorescent pictures were always taken at the 
same exposure time to generate comparable results.   
 
Late outgrowth EPCs were cultured statically or conditioned at pulsatile shear stress 
of 1.0 Pa for 24 h. Afterwards they were compared by real-time PCR regarding their 
expression levels for PECAM-1 and VEGFR-2. In addition, expression levels for von 
Willebrand Factor (vWF) and endothelial nitric oxide synthase (eNOS) were also 
examined.  
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Figure 50 A comparative real-time PCR was performed comprising RNA from static 
cultured late outgrowth EPCs and late outgrowth EPCs that were subjected to 
pulsatile shear stress of 1.0 Pa for 24 h.  Relative expression levels for PECAM-1 
(CD31) [green], KDR/VEGFR-2 (CD309) [red], von Willebrand Factor (vWF) [blue] 
and endothelial nitric oxide synthase (eNOS) [black] are shown. Confidence interval 
is 95% (n=3). 
 
Pulsatile laminar shear stress of 1.0 Pa - molecular biological analysis (n=3) 
 
Pulsatile shear stress of 1.0 Pa reduced the expression of PECAM-1 (green) to about 
60%. Expression of vWF (blue) was reduced to about 50%. Expression for eNOS 
(black) was reduced to 0%. For VEGFR-2, no significant change in expression could 
be observed (Figure 50). 
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3.3.3 Nitrogen oxide production under pulsatile shear stress  
 
Exposure of late outgrowth EPCs to various pulsatile shear stress levels for 24 h did 
not cause any production of nitrogen oxide. The Griess assays were always proven 
functional by the preparation of a standard curve. The results from Griess assays 
revealed that the level of nitrogen oxide was similar to that of pure medium and 
medium from cells after static cultivation.  
 
 
3.3.4 Homing of early EPCs under pulsatile flow conditions 
 
The homing capacity of early EPCs under pulsatile flow conditions was examined. 
Therefore, human EPCs isolated from peripheral blood were placed in the parallel 
plate flow system and subjected to 0.45, 0.7 and 1.0 Pa of pulsatile shear stress. 
LumoxTM slides were left blank or coated with fibronectin, gelatin, galectin-3, galectin-
8 or BSA. Experiments were run for 3 h, 24 h or 72 h (each n=3). Attachment was 
monitored with a microscope camera (T.I.M.M. - 400 SPI Robots) at a single spot and 
under a bright field microscope to examine the whole slide area.  
No cell attachment could be observed for any of the above mentioned coatings, 
shear stresses or exposure times. At long-term exposure (24 h and 72 h), cell death 
was one possible reason for this absence of cell attachment in the Taylor-Couette 
system.  Consequently, to examine if this was again the case, EPCs were harvested 
after each run and seeded on fibronectin coated LumoxTM slides. Similar to the 
situation in the Taylor-Couette system, cells exposed to 24 h and 72 h of shear stress 
were no longer viable. In contrast to the Taylor-Couette system, cells were also non 
viable after only 3 h of pulsatile shear stress exposure. 
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3.4 Employing early outgrowth EPCs for the endothelialization of the BioStent  
 
In order to examine the feasibility of EPCs for tissue engineering purposes, the 
BioStent project was chosen.  
The BioStent was assembled as previously described (material and methods 2.2.15). 
In order to investigate the potential of EPCs for lining purposes in the BioStent, 
progenitors were isolated from peripheral blood and seeded on the graft surface as 
early EPCs. Three different setups were used to investigate a potential benefit from 
the process. First, HUVECs were seeded on the surface of the BioStent which 
represents the usual endothelialization procedure. Secondly, a co-culture of HUVECs 
and EPCs was used. Finally, EPCs were seeded alone. Before use, EPCs were 
incubated with DiI-ac-LDL in order to stain them for later visualization on the stent 
surface.  
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3.4.1 DiI-ac-LDL labelled EPCs in the BioStent 
 
After seeding of HUVECs, HUVECs + EPCs and EPCs, all BioStents were incubated 
for one week to allow the cells to cover inner surface of the stents. Thereafter, stents 
were examined under a fluorescence microscope (Zeiss Axio Observer Z1) to 
visualize the DiI signal of ac-LDL labelled EPCs. The standard BioStent with 
HUVECs did not show any signal and there was no fluorescent background (Figure 
51 A). The co-culture of HUVECs and EPCs revealed only a few scattered EPCs 
(Figure 51 B). Finally, the BioStent that was seeded only with EPCs showed 
remarkably more fluorescent signal although still very scattered (Figure 51 C). 
Hence, EPCs did not cover the graft surface sufficiently neither in a co-culture nor in 
a single culture approach.  
 
Figure 51 Fluorescent images of the inside of three BioStents. A standard Biostent 
seeded only with HUVECs did not show any fluorescence signal (A). In the co-culture 
setup scattered EPCs (red) can be seen on the surface of the stent (B). The surface 
of the stent that was seeded with EPCs only, shows even more scattered 
fluorescence signals of EPCs (red) than the co-culture (C). (Courtesy of Lisanne 
Rongen (modified)). 
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3.4.2 Results of the SEM analysis 
 
To further examine the distribution of cells on the BioStent surface, SEM (scanning 
electron microscopy) images were taken at 18x, 150x and 600x magnification for 
each of the three approaches. The regular BioStent setup with HUVECs yielded a 
uniform layer of cells on the surface of the stent lumen (Figure 52 A,B,C). The co-
culture setup with HUVECs and EPCs resulted in layer that was still uniform. 
However, the cells of this layer were very elongated and there was uncovered space 
between these cells (Figure 52 D,E,F). Finally, in the approach using only EPCs, no 
layer was visible in the end. Instead, aligned and elongated cell were present (Figure 
52 G,H,I). 
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Figure 52 SEM (scanning electron microscopy) images from the inside of three 
different seeding approaches of a BioStent. A, B and C show different magnifications 
(18x, 150x and 600x) of a regular BioStent seeded with HUVECs alone. D, E and F 
show different magnifications (18x, 150x and 600x) of a BioStent seeded with a co-
culture of HUVECs and EPCs. G, H and I show different magnifications (18x, 150x 
and 600x) of a BioStent seeded only with EPCs. At higher magnification an uniform 
layer of HUVECs can be seen (B, C) while in co-culture (E, F) the layer is less 
uniform and cells are very elongated. The BioStent seeded with a single culture of 
EPCs (H, I) shows no more layer but only elongated cells. (Courtesy of Lisanne 
Rongen (modified)). 
 
Taking these results together, it is clear that HUVECs used in the regular BioStent 
setup form a uniform and confluent layer of cells. EPCs alone, on the other hand, did 
not form a cell layer similar to that of HUVECs. In addition, they did not cover the 
whole area of the stent lumen but were rather scattered over the surface. EPCs in the 
co-culture with HUVECs were even more scattered over the stent surface that EPCs 
alone. The cell layer formed in the co-culture setup was unlike that of regular 
HUVECs. Cells were more elongated and had gaps in between.  
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3.5 First test of the novel pulsatile Taylor - Couette 
 
Of note, with regard to the restricted time schedule at the end of this study the test 
period for the novel pulsatile Taylor-Couette system was very restricted, which is why 
the test results display only an initial overview.  
 
Both modules were manufactured from PMMA to reduce weight of the system and 
provide a material that is easy to sterilize and cost effective. However, PMMA was 
poorly suited as material. First, PMMA is heat sensitive and has to be sterilized with 
plasma instead of being autoclaved. After plasma treatment, it takes at least seven 
days for PMMA to degas from substances which are harmful to cells. Alternatively, 
gamma irradiation could be employed for sterilization but it is expensive. 
Furthermore, the mechanical properties of the PMMA are insufficient. Hence, 
although threads of the system were enforced additionally with metal coils especially 
available for this material, they were destroyed quickly by slight tightening of screws. 
Perhaps this was due to the circular shape of the system or internal tensions of the 
PMMA. Usually, parts composed of PMMA are reamed from commercially available 
extruded PMMA rods. Tension in the raw material is then orientated in a certain 
direction. By chance, the system was shaped in an unfavourable orientation 
regarding the inner tension of the raw material.  
Without intact threads, the system could not be assembled, and as a consequence 
further feasibility studies, including cells experiments, have not yet been performed.  
Future systems should be made of stainless steel instead of PMMA. In a system 
produced from metal, the walls of the system can be thinner and threads shorter 
while still maintaining the required stability. In addition, stainless steel can be 
autoclaved and used immediately after cooling.  
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4. Discussion 
 
4.1 Phenotype shift of EPCs under various flow conditions 
 
Most cells require contact with their environment in order to react in response to 
changing conditions. Parameters detected by a cell can be, for example, pH, 
temperature, osmotic pressure or concentration of nutrients or toxic substances. One 
parameter that is crucial for ECs and potential precursors, the EPCs, is shear stress 
that results from the blood flow in the vasculature. Effects of steady/pulsatile laminar 
shear stress and turbulence on EPCs were investigated by means of two distinct 
devices. 
 
Shear stress rates in both apparatuses were always kept similar to permit 
comparability. In the Taylor-Couette system, cells were exposed to a steady laminar 
shear stress of 0.85 Pa, low or high turbulence. Within the parallel plate flow 
chamber, cells were exposed to laminar pulsatile shear stress of 0.45, 0.7 and 1.0 
Pa. These shear rates resemble either the conditions in small vessels and capillaries 
or turbulence from atherosclerotic regions.  
 
Changes in morphology of EPCs after shear stress exposure was visualized with the 
attached microscopy system. Moreover, expression levels of shear stress responsive 
endothelial proteins - PECAM-1, VEGFR-2, vWF and eNOS - were examined at 
transcriptional and translational levels. The amount of nitric oxide in the medium was 
estimated to determine whether or not the employed shear stress conditions 
stimulated the nitric oxide synthesis of the cells. 
In the following chapters, the phenotype shift of the cells discovered through this 
work will be compared to data obtained from literature.  
 
 
 
 
 
124 
 
4.1.1 Elongation in direction of flow 
 
It has been reported that EPCs subjected to shear stress in a laminar flow chamber 
orient themselves in the direction of flow similar to ECs [103]. However, this could not 
be observed in the current study with late outgrowth EPCs derived from human 
peripheral blood. Cells subjected to steady or pulsatile laminar shear stress flattened 
themselves instead of orienting in the flow direction. The same occurred at turbulent 
conditions. One reason for this adverse behaviour might be the difference in shear 
stress rates. The maximum shear stress rate in this study was 0.85 Pa (steady) and 
1.0 Pa (pulsatile), while in the aforementioned study, cells were subjected to shear 
stresses of 1.5 Pa.  Nevertheless, in an earlier study with EPCs, even lower shear 
stresses were applied (0.1 - 2.5 Pa) and still elongation of the cells was observed 
[104].  
Therefore, it appears more likely that use of different cell types could explain altered 
findings between the current study and others. Not only were different species 
utilised, but the cell sources were also different. There is still a lack of a final 
definition of an EPC - both early and late outgrowth. Pulsatility can be excluded as an 
explanation for the contradictory findings as EPCs were exposed to both steady and 
pulsatile shear stress. The resultant behaviour of EPCs under both conditions was 
similar.  
 
4.1.2 Short versus long time exposure 
 
In previous studies involving shear stress, EPCs have usually been exposed to fluid 
flow for at least 24 h [76, 84, 87, 104]. In order to shorten shear stress experiments, 
an exposure time of 3 h was compared to 24 h under both steady and pulsatile 
conditions in the current study. For both conditions, the lowest stress setups from 
succeeding experiments were used (pulsatile: 0.45 Pa /steady: 0.85 Pa).  This was 
performed to ensure that even changes caused by the lowest forces can still be 
monitored after the given time period.  
Expression levels of PECAM-1 (CD31) and VEGFR-2 (CD309) were determined with 
immunofluorescence imaging and served as a measure of the effects of shear stress 
on the cells.  
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Neglectable effects on the expression of both proteins were observed after 3 h, not 
as apparent as the effects after 24 hour exposure. In the steady laminar flow of the 
Taylor - Couette system, cells showed less expression of both proteins after 3 h, 
while in the pulsatile device, expression remained slightly elevated. However, after 24 
h almost the entire signal for each of the two proteins was abolished under steady 
and pulsatile conditions. To conclude, exposure for 3 h was not feasible as it did not 
reveal the entire effects of shear stress on the cells. Furthermore, long-term exposure 
more likely reflects the in vivo situation to a greater extent. Consequently, in order to 
concentrate on more realistic conditions all experiments were performed for the time 
span of 24 hours. 
 
4.1.3 PECAM-1 (CD31) and VEGFR-2 (CD309) expression 
 
In 2005, a novel mechanosensory complex was described in a publication in the 
Nature journal. Two of three key proteins were PECAM-1, responsible for direct 
transmission of mechanical force, and VEGFR-2 that activates phosphatidylinositol-3-
OH kinase [105]. In vivo experiments with PECAM-1 knockout mice supported the 
important role of this protein. NF-kappa B-dependent inflammatory response was not 
activated in regions of disturbed flow in these mice. To summarise, the presence of 
both proteins is crucial for functional endothelial cells. Considering these findings, 
late outgrowth EPCs, which are supposed to resemble the mature endothelial cell 
phenotype to a greater extent, should also express these proteins. Moreover, under 
shear stress exposure, the expression of the described proteins should be even 
further enhanced through the stimulation.  
Late outgrowth EPCs isolated from human peripheral blood were subjected to steady 
(0.85 Pa), pulsatile (0.45, 0.7 and 1.0 Pa) shear stress and turbulence (low/high) for 
24 h and investigated by both immunfluorescent imaging and comparative real-time 
PCR for expression of PECAM-1 and VEGFR-2. 
 
PECAM-1 
 
Immunfluorescent images showed reduced levels of PECAM-1 after steady shear 
stress treatment at 0.85 Pa and at low and high turbulence. Real-time PCR data 
supported these findings.  PECAM-1 expression was reduced to about 50% of the 
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statically cultured control at 0.85 Pa and to about 25 % for low and high turbulence. 
Pulsatile shear stress had an altered influence on PECAM-1 expression. In 
immunfluorescent images from the pulsatile flow, only slight reduction in expression 
could be observed for 0.45 and 0.7 Pa, while at 1.0 Pa the signal was abolished 
almost completely. Data from real-time PCR showed an increase of 25% for 0.45 Pa 
and decrease of 50% for 1.0 Pa. No significant real-time PCR data was available for 
0.7 Pa, however the tendency was rising.  
Taken together, these results suggest that pulsatility does have a positive influence 
on the expression of PECAM-1 in late outgrowth EPCs, while steady laminar shear 
stress and turbulent flow do not. Laminar and pulsatile shear stress rates were similar 
in both systems, but under steady flow, expression of PECAM-1 dropped, whereas 
under pulsatile flow, expression did not drop until shear stresses of 1.0 Pa were 
encountered. To conclude, at the investigated shear stress rates, pulsatile laminar 
flow has positive- and steady laminar flow has negative effects on expression of 
PECAM-1 in late outgrowth EPCs. However, at higher shear stress levels (1.0 Pa), 
this effect is abolished. One reason may be the coupling of flow rate and pulse 
frequency in the parallel plate flow chamber that was driven by a tubing pump.  The 
flow rate required for 1.0 Pa shear stress may have generated a non-physiological 
pulse rate for this shear stress.  
In the literature, an increase of PECAM-1 was reported but these results were 
obtained with a murine embryonic mesenchymal progenitor cell line and at higher 
steady shear stress (1.5 Pa) [106]. Moreover, stimulation time was only 6 and 12 h 
which is quite a short time period compared to 24 h. The importance of an adequate 
time period was reported in previous chapters. Taking all of this into account, reliable 
comparison between both studies is not possible.  
There are no studies in the literature at the present time on the effects of turbulent 
flow on late outgrowth EPCs in respect of PECAM-1. However, negative effects, like 
development of atherosclerosis in response to turbulent or low steady laminar shear 
stress, have been previously reported for mature ECs [107]. These flow patterns 
could have influenced the late outgrowth EPCs from this work in a similar manner. 
This might be of particular interest when implanting tissue-engineered constructs like 
grafts that employ EPCs as a lining. At anastomotic sites, turbulent flow patterns 
often arise and act on the lining cells influencing them in the aforementioned manner. 
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VEGFR-2 
 
Immunofluorescence analysis demonstrated a major reduction of VEGFR-2 
expression in cells that were exposed for 24 h to steady laminar shear stress of 0.85 
Pa. Real-time PCR data underscored this findings showing evidence for a reduction 
to about 50% in VEGFR-2 expression. Low and high turbulence conditions also 
caused a decrease in fluorescence signal. Data from real-time PCR was not 
significant for turbulent conditions, but a decreasing tendency could be observed. 
Pulsatile shear stress caused only slight fluorescence signal reduction for VEGFR-2 
at 0.45, but the decrease in signal was visible at 0.7 Pa and even more so at 1.0 Pa. 
Data for 0.7 Pa was supported by real-time PCR results that reveal a decrease to 
10% expression of the statically cultured control. However, real-time PCR results for 
the other investigated shear stress rates are not significant and do not even show a 
clear tendency.  
For endothelial cells, VEGFR-2 expression was found to increase with rising 
exposure time (1-12 h) to steady shear stress [108]. Interestingly, this was only true 
for high shear stress (2.0 Pa), while at low shear stress (< 0.2 Pa), no increase in 
VEGFR-2 expression could be shown. Another study compared the influence of 
various shear stress levels on VEGFR-2 expression of human peripheral blood 
EPCs. The cells where investigated at rising maturation states ranging from early to 
late outgrowth EPCs and with steady shear stress in a range from 0.01 - 0.25 Pa for 
24 h [104]. Higher shear stress (range: 0.14 - 0.25 Pa) was more effective in 
promoting VEGFR-2 expression than lower shear stress (range: 0.01 - 0.13 Pa). 
Moreover, increased VEGFR-2 expression was observed in early and mid-aged 
EPCs, but not in late outgrowth EPCs.  
Comparison of data from the present study with results from previous studies is 
difficult due to varying shear stress rates, flows profiles (steady/pulsatile/turbulent) 
and exposure times. In addition, one of the reported studies employed ECs instead of 
late outgrowth EPCs. Nevertheless certain facts can be correlated. Shear stress of 
0.25 Pa did not affect VEGFR-2 expression of late outgrowth EPCs. This is similar to 
findings for ECs that also demonstrated no increase in VEGFR-2 expression at lower 
shear stress (< 0.2 Pa) [104, 108]. The lowest shear stress used in the present work 
was pulsatile and at 0.45 Pa. This shear stress is almost twice as high compared with 
the values from the literature, and under these conditions, expression of VEGFR-2 
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was reduced in late outgrowth EPCs. This reduction increased with a rising pulsatile 
shear stress and could also be observed for steady laminar shear stress of 0.85 Pa, 
in addition to turbulence. Turbulence and low shear stress could have negative 
effects on EPCs, which is similar to the situation observed with mature ECs [107]. 
Higher shear stresses than those used in the present work might be required to 
positively stimulate the VEGFR-2 expression of late outgrowth EPCs. In the study 
with endothelial cells, an increase in VEGFR-2 expression could only be observed at 
high shear stress (2.0 Pa) [108].  
Taken together, pulsatile laminar shear stress in the range of 0.45 - 1.0 Pa and 
steady laminar shear stress of 0.85 Pa reduce the VEGFR-2 expression of late 
outgrowth EPCs in the same negative manner as turbulence. The current Taylor-
Couette system is limited to a maximum steady laminar shear stress of 0.85 Pa. 
Hence, to investigate the VEGFR-2 expression at 2.0 Pa, a different system to the 
current system has to be employed. The new pulsatile Taylor-Couette system, 
presented in the “outlook” chapter of the present work, provides steady laminar shear 
stress in a range from 0.4 - 2.0 Pa and could be used for this purpose. 
 
4.1.4 Expression of eNOS and production of nitrogen oxide (NO) 
 
Production of NO in response to shear stress is one of the key functions of mature 
ECs in vasculature [3]. Therefore, in the present study, late outgrowth EPCs from 
human peripheral blood were examined for their potential to produce NO. 
Consequently, they were exposed to different flow types and shear stress for 24 h. 
Thereafter, the medium used for their supply was examined for released NO. None of 
the aforementioned conditions yielded any production of NO in the present work. This 
finding was surprising considering the literature data from an earlier study where 
shear stress-dependent nitrogen release was shown after 4 h of shear stress 
exposure [76]. Increasing shear stress rates (0.5, 1.5 and 2.5 Pa) were also shown to 
increase the release of NO (~4-fold, ~6-fold and ~9-fold above the level of the 
statically cultured control). Of interest, eNOS levels investigated by comparative real-
time PCR also rose, but to a lesser extent (2-fold, 2.8-fold and 3-fold). This 
discrepancy could not be explained by the authors. The choice of a reliable reference 
gene for a comparative real-time PCR is crucial. In the study, the gene for beta-actin 
was used for this purpose. This appears to be an inappropriate choice considering 
129 
 
the remodelling of the cytoskeleton that occurs with orientation of the cell in the 
direction of flow. Therefore, data from this real-time PCR analysis is not really reliable 
and rightly doubted by the authors themselves. Therefore, in the present study, 
GADPH was chosen as a reference gene for comparative real-time PCR analysis 
and shear stressed cells were compared with cells from static cultivation. Steady 
shear stress at 0.85 Pa and low turbulence had no significant influence on eNOS 
expression, but at high turbulence, a reduction of expression to 25% could be 
observed. Pulsatile shear stress had no significant influence on eNOS expression at 
0.45 and 0.7 Pa, but was dramatically reduced to 0% at 1.0 Pa. Thus, higher pulsatile 
shear stress and high turbulence exert a negative effect on eNOS expression. 
Surprisingly, pulsatile steady shear stress (reduction to 0% expression) affected the 
EPCs even more than high turbulence (reduction to 25% expression). This contrasts 
with the fact that pulsatility resembles the in vivo situation and stimulates the cells 
positively. Perhaps the employed shear stress rates were too low. Future studies with 
the new Taylor-Couette system could solve this problem as it provides shear stress 
up to 2.0 Pa. 
Considering the shear stress dose-dependent NO production reported in the 
literature, further research at shear stress rates above 1.0 Pa will be necessary to 
finally clarify this issue in the present setup. The expression levels of eNOS 
estimated in the present work changed markedly in response to different flow 
regimes, but no production of NO could be measured.  This could be explained by an 
inauspicious cell to medium ratio of the applied shear stress devices from the present 
work. The amount of NO may also be diluted by the medium to an undetectable 
concentration. Ultimately, the measurements were performed after 24 h and not after 
4 h as in the former study. This could have caused NO loss and might be another 
possible reason for the low levels of this gas. 
 
4.1.5 Expression of the von Willebrand Factor (vWF) 
 
The vWF is produced by ECs and megacaryocytes (bone marrow cell responsible for 
the production of blood platelets). It exerts a pro-coagulant function supporting the 
adhesion of platelets to blood vessels and binds to factor VIII (anti-hemophilic factor) 
protecting it from proteolysis [109]. All of these functions are very important for 
endothelial cells. Considering this, late outgrowth EPCs should also express vWF in 
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order to resemble the endothelial cell-like phenotype. This should particularly be the 
case under shear stress conditions, as these reflect for the most part the in vivo 
conditions of mature endothelial cells.  Expression of vWF under shear stress was 
examined with umbilical cord blood-derived EPCs in co-culture with smooth muscle 
cells or seeded alone [85]. The highest expression of vWF was observed in this study 
using a combination of co-culture and shear stress exposure. EPCs from umbilical 
cord blood were subjected to shear stresses of 0.5 Pa for 12 h, while in the current 
study, late outgrowth EPCs from human peripheral blood were treated with shear 
stress for 24 h before examination for vWF expression with comparative real-time 
PCR. In contrast to the findings in the literature, no significant difference at steady 
laminar shear stress of 0.85 Pa and low turbulence could be observed in comparison 
to statically cultured cells, but at high turbulence, the expression decreased to about 
25% of that of statically cultured cells. This could explain the fact that the shear 
stress device from that study operated in pulsatile and not steady laminar modus. 
Appling pulsatile shear stress to late outgrowth EPCs in the parallel plate chamber 
caused an increase at 0.45 and 0.7 Pa to 200 and 250% of the static control, which 
reflects findings from the literature. At pulsatile flows of 1.0 Pa, on the other hand, the 
expression level dropped by 50 %. To conclude, high shear stress negatively 
influences the expression of vWF in EPCs, which is supported by the results from the 
current study for high turbulence that show a reduction to about 25%. Under turbulent 
conditions, high shear stress usually develops.  
The different results of the present study compared to the previous study could be a 
result from shorter exposure time (12 h vs. 24 h), different cell types (peripheral blood 
and umbilical cord blood derived EPCs), or co-culture (EPCs plus smooth muscle 
cells in the literature study).  
 
4.2 Homing of EPCs 
 
Homing of EPCs describes a process of differential migration and attachment from 
the circulation to specific areas. Ischemic regions and denuded vessel walls are 
prone to attract endothelial progenitors from the circulation [110]. Homing of EPCs 
under flow conditions in vitro has been investigated with a parallel plate flow chamber 
and revealed the important role of CXCR2 and its ligands for the EPC homing [111]. 
Other studies demonstrated the importance of integrins for homing [73, 112].  
131 
 
Both shear stress systems were used to address the issue of EPC homing in the 
present study. The LumoxTM slide surface was either left blank or coated with 
different agents (fibronectin, gelatin, galectin-3 and galectin-8) to promote attachment 
and successive proliferation of the cells. BSA (bovine serum albumin) served as a 
control. Various shear stress conditions were used to address this question. Steady 
laminar shear stress (0.85 Pa), pulsatile laminar shear stress of (0.45 Pa, 0.7 Pa and 
1.0 Pa) and turbulence (low/high) were applied for 3 h, 24 h or 72 h to the cells. None 
of the applied conditions revealed a successful homing of EPCs. It the following 
sections, possible reasons for this finding will be discussed. 
 
4.2.1 Different cell types and coatings 
 
In contrast to the study focusing on CXCR2 [111], cells for the experiments were not 
cultured 7 days in advance of experiments. Moreover, the mononuclear blood fraction 
including EPCs from the circulation was injected into both shear stress systems 
directly after isolation. As a consequence, homing experiments were closer to the in 
vivo situation where EPCs home directly from the flow and are not pre-cultured in 
advance. In addition, EPCs from various organisms and varying sources were used 
in the studies including the present one. Considering the on-going heated and 
justified debate about the definitive phenotype of an EPC, proper judgment between 
the results of studies appears hardly possible. Still, tendencies can be deducted from 
comparisons.  
Not only were the EPC types different across studies in the literature, but also the 
coatings selected for adhesion promotion. This is the most significant difference 
between the current and all previous studies and might be an important reason for 
the lack of homing. However, different aspects of adhesion were investigated and 
examined from different angles, which consequently causes difficulties in comparison 
of the results. At the moment, the homing mechanism of EPCs is unravelled to a 
small extent only, but has already been shown to be highly complex, involving the 
interaction of multiple signalling molecules [113]. Taking this into account, in vitro 
testing devices can solely serve to elucidate certain isolated aspects of this topic, but 
will fail to demonstrate the entire process.  
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4.2.2 Various shear stress levels and exposure times  
 
At steady laminar flow in the current Taylor - Couette system, no pulsatility was 
present. This is a non-physiological condition and could be another reason for the 
absence of homing by EPCs. For this reason, experiments were run additionally with 
the parallel plate flow chamber system to exclude this point. The flow chamber is 
driven by a peristaltic pump and generates pulsatile flow, resembling the conditions in 
the native circulation more closely. This approach also failed to achieve homing. 
Perhaps this was again a consequence of mismatched pulse frequency and flow rate. 
Finally, low and high turbulence conditions were also tested but without success. 
Perhaps the emerging shear stresses under given turbulence conditions have been 
too high to permit adhesion of the cells. Shear stress rates were performed at a 
maximum of 1.0 Pa while in the previous study with CXCR2, a shear rate of 1.5 Pa 
was used. This is a huge discrepancy and another possible reason for the different 
outcome of homing experiments of both studies.  
Adherence from the flow was already observed 4 min. after injection in an earlier 
study [111]. This is a very short timeframe compared to the exposure times of 3 h, 24 
h and 72 h used in the present work. In addition, no follow up investigation was 
performed to monitor if bound cells detach over time and if suspended non-bound 
cells survived. Considering the in vivo situation where EPCs are supposed to home 
to denuded vessel walls and differentiate into mature endothelial cells, long-term 
monitoring appears more beneficial. Therefore, another possible reason for the 
absence of homing after 24 and 72 h was that cells died after 24 h in the Taylor - 
Couette system and after only 3 h in the pulsatile system. This was demonstrated by 
seeding of the suspended cells from the systems onto regular tissue culture flasks 
after ever homing experiments. A possible reason for cell death after long-term 
incubation could be the absence of any adhesion possibility. It is well known that 
adhesion is very important for human cell survival. In the pulsatile system, cells were 
already non-viable after 3 h. This is most likely due to the pump head valves of the 
tubing pump. It is highly likely that cells were mechanically damaged by the pumping 
process. Moreover, the current experiment was even very simplified compared to the 
native conditions. It is very unlikely that cells in the human circulation pass the same 
spot of the vasculature as often as it occurs in any of the mentioned studies including 
also our own study. 
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4.3 Applications of EPCs for the BioStent 
 
The BioStent construct was employed to estimate the potential of early EPCs as a 
lining of tissue-engineered constructs. SEM images revealed that the cell layer 
formed by EPCs or a combination of EPCs and HUVECs (seeding ration 1:1) was 
completely different compared to the surface created by HUVECs. The HUVECs 
layer was confluent and cells were flattened covering the whole surface. Mixing EPCs 
and HUVECs yielded a surface of flattened but elongated cells with huge gaps in 
between. Finally, EPCs alone did not form a cell layer at all, only the underlying 
fibroblast cell layer was visible in SEM images. 
One of the possible reasons for these findings could be that the employed EPCs and 
HUVECs were not derived from the same patient. There might have been a negative 
interaction between them which is though rather unlikely considering the absence of 
an immune system under these in vitro conditions.  
Another possibility for the poor performance could be the choice of early EPCs as a 
cell source. Considering the higher similarity to mature EC, late outgrowth EPCs 
could be a better choice. However, these cells were difficult to detach from the cell 
culture flasks and yielded only low cell numbers thereafter. Future experiments with 
late outgrowth EPCs might unravel this issue.  
Only very few and scattered EPCs were visible in the fluorescent images of the stent 
surface. Therefore, the amount of cells that managed to bind during the 6 h of 
endothelialization may have been too low.  
Beneficial paracrine effects from early EPCs on mature ECs have been reported 
previously in the literature [51, 52]. In the mixed setup of the present study, EPCs 
were not advantageous for the formation of a confluent mature endothelial cell layer. 
Nonetheless, the disturbed confluence of the cell layer might also be a consequence 
of the reduced number of HUVECs in this mix.  
Concisely, early EPCs are not a suited substitute for HUVECs. Similar experiments 
with late outgrowth EPCs are required to figure out if they might be a better choice for 
lining purposes. This on the other hand does not appear probable considering the 
described phenotypic change of late outgrowth EPCs under shear stress influence 
(chapter 4.2).  
There are reports regarding stents with molecules on the stent struts that promote 
binding of circulating EPCs directly from the blood after implantation [114-116]. 
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However, the space between the struts is still not covered by the stent entirely. 
Therefore, the atherosclerotic plaque can still grow and restenosis the vessel. This is 
different in the case of the BioStent where after pre-cultivation in the bioreactor the 
stent struts and also the space between the struts are completely coated by 
connective tissue with an endothelialized lumen. Perhaps a combination of both 
principles would be the best solution. A BioStent with an EPC-capturing coating at 
the inside could comprise both advantages and therefore be a good future approach.  
 
 
4.4 Feasibility of the current Taylor - Couette based system for shear stress 
analysis of EPCs  
 
Over the past decades, various devices based on different principles have been used 
for shear stress experiments with cells. All of these devices were constructed with the 
goal to generate a laminar flow that most accurately mimics in vivo conditions. For 
the present body of work, an innovative Taylor-Couette flow-based system was used. 
Due to its geometry, the device is capable of generating steady laminar flow patterns 
up to 0.85 Pa. Moreover, turbulence can also be generated with this device at will. By 
combining microscopy techniques, imaging of cells is permitted during experiments 
and LumoxTM slides provide optimal gas exchange. Nevertheless, the present system 
is a laboratory prototype and therefore still has disadvantages that will be discussed 
in the subsequent chapters.  
 
4.4.1 Bulging of slides 
 
One major advantage and at the same time crucial disadvantage of the apparatus is 
its small size. On the one hand small size means low volume, which is important 
considering the expense of EPC-specific medium. On the other hand, the small size 
means that the diameter of the outer cylinder is small, leading to a strong bulging of 
the inserted slides. As a consequence, the slide surface is no longer flat but becomes 
wavy and hence the system (theoretically) fails to generate perfectly defined laminar 
flow. Interestingly, Simone Wirz (MD thesis in progress, RWTH Aachen University) 
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proved that even with bulged slides, laminar flow is still possible with this apparatus, 
which was demonstrated using PIV (particle image velocimetry).  
Further bulging also caused problems for immunofluorescence analysis. This is 
because slides maintained the curvature of the outer cylinder despite being removed 
from the system. A minor curvature of slides could be compensated by time-
consuming focus adaption with the Zeiss Software AxioVision (Version 4.8.2.). At 
major curvatures of the LumoxTM slide, the foil with cells had to be removed from the 
carrier and placed on glass slides for microscopic analysis. This is a very time 
consuming process and orientation of the slide can be easily lost when the foil 
detaches from the glass slide. Future systems, such as the new pulsatile Taylor-
Couette system, should have larger diameters to overcome this problem even at the 
price of elevated medium consumption. 
 
4.4.2 Missing scales and blurred images 
 
With the attached microscope system, real time monitoring of the slide surface was 
possible. However, there were some drawbacks to this. One drawback is that the 
available system provides no information in the image regarding the magnification 
factor. No scale bars were available. This could be easily circumvented by 
purchasing the required software update. However, for the laboratory prototype, 
current software was sufficient, as scales in later immunofluorescence images permit 
the estimation of cell size with ease.  
Images acquired by the attached microscope were often blurred, as it was not 
incorporated in the device but rather mounted on a separate tripod stand. Minor 
vibrations were sufficient to cause significant blurring which is exacerbated by the 
large magnification ratio. This problem was resolved by a combination of factors. 
Firstly, the tripod was positioned to touch the magnetic stirrer, thereby achieving 
simultaneous movement of both in response to vibration. Then, the effective mass of 
the tripod was increased to reduce its own resonance frequency.  
 
 
 
136 
 
4.4.3 Magnetic stirrer - drawbacks of the system drive 
 
The shear stress apparatus can be used with any standard laboratory grade 
magnetic stirrer, which is advantageous as it avoids costs for an additional motor unit 
and reduces the total costs of the system. In addition, the inner cylinder of this 
system is driven by magnetic forces only. For this reason, no shaft is necessary to 
penetrate the shelf of the system which would make it prone to leakage and 
contamination. Adequate sealing of such a shaft is hardly possible due to its 
requirement for movement. However, two problems were encountered working with 
the system.  
Firstly, most common magnetic stirrers are not suitable for use in a humidified 
atmosphere and therefore water tight stirrers had to be used for driving the system. 
These are very expensive and also produce a vast amount of expended heat which 
warms the medium in the shear stress device to a level that is non-physiological for 
the cells. This problem was solved by spacer elements at the base that prevented 
direct contact of the device and stirrer.  
At lower rotation speeds, the drive profile of the magnetic stirrer was not smooth and 
the motion of the inner cylinder was uncontrolled. Of course, this impairs 
development of the appropriate flow patterns. Nevertheless, the target shear stress 
rates never required such low rotation speeds. 
A further problem with the device was the acceleration phase. The magnetic coupling 
force was not strong enough to compensate the inertia of the inner cylinder when 
accelerating too fast. This problem could be solved by a reduced increase in speed.  
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5. Conclusions 
 
Endothelial progenitor cells are used in clinical applications as they can be easily 
isolated from patients’ blood and comprise both diagnostic and healing properties. 
For cardiovascular tissue engineering, the most important feature of EPCs is their 
potential to differentiate towards an endothelial-like cell type. In future, endothelial 
progenitors were proposed to serve as cell source for lining of tissue-engineered 
constructs such as a vascular stent, a vascular graft or other constructs that have 
blood contact and need a hemocompatible surface.  
The aim of this work was to evaluate the suitability of EPCs for lining purposes. 
Therefore, homing potential and response to various shear stress conditions of EPCs 
were examined. Of note, the effects of turbulence were also included in the shear 
stress investigation. Until now, the influence of turbulent flow regimes on EPCs has 
not been explored. This is surprising because EPCs were reported to home to 
denuded vessels at atherosclerotic lesions. In a region with atherosclerosis, the 
laminar blood flow is disturbed by the plaque and can become turbulent. Homing of 
EPCs should hence be examined under laminar and pulsatile flow conditions, but 
also under turbulent conditions. Furthermore, it is also of interest to determine how 
turbulence influences EPCs that are already adhered and serve as a lining, i.e. for 
tissue-engineered constructs. 
A novel Taylor - Couette flow-based shear stress device, able to generate laminar 
steady shear stress (0.85 Pa) or turbulence (low and high), and a parallel plate flow 
chamber, providing pulsatile laminar shear stress (0.45 Pa, 0.7 Pa and 1.0 Pa), were 
employed to research the homing of EPCs and their response to shear stress.  
Homing experiments were performed with very early EPCs to best possibly mimic the 
in vivo situation, where EPCs home directly from the blood flow. The cells did not 
bind to the surface under any of the applied shear stress conditions. Even when 
using various coatings (fibronectin, gelatine, galectin-3, galectin-8 or BSA) instead of 
a blank slide, no attachment of cells could be observed. In conclusion, the potential 
of circulating EPCs to home to a surface could not be demonstrated. Homing in vivo 
might include molecules other than those investigated, e.g. integrins. Cytokines 
and/or chemokines may perhaps also play a role in this process.  
In the literature, late outgrowth EPCs have been reported to possess a phenotype 
that is most similar to that of mature endothelial cells. Thus, they could serve as a 
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lining substitute for mature ECs because they can be isolated with ease from 
patients’ blood and do not require any surgery. To be adequate for this purpose, late 
outgrowth EPCs should maintain or even enhance their endothelial-like phenotype 
under the influence of shear stress. Mature ECs are always subjected to shear stress 
and respond to it. In the present work, the reaction of late outgrowth EPCs to diverse 
shear stress conditions was assessed. To quantify this response, expression of 
important shear stress-related, endothelial proteins (PECAM-1, VEGFR-2, eNOS and 
vWF) was measured at both transcriptional and translational levels. In contrast to 
data from the literature, expression of all proteins dropped markedly after exposure to 
steady laminar shear stress (0.85 Pa for 24 h). This effect was also visible after 
stimulation with pulsatile shear stress (0.45 Pa, 0.7 Pa and 1.0 Pa for 24 h), but to a 
lesser extent. Finally, low and high turbulence conditions (24 h) led to reduction of 
expression comparable to that of laminar steady flow. Taken together, late outgrowth 
EPCs lose their endothelial-like phenotype under exposure to shear stress. This 
effect is slightly reduced under pulsatile conditions, which more closely mimic the in 
vivo environment. The functional analysis for nitrogen oxide production by late 
outgrowth EPCs supports these findings. Under none of the applied shear stress 
conditions could a production of this gas, which plays a key role in the regulation of 
vascular tone, be confirmed. In the literature, elevated levels of nitrogen oxide were 
reported. Morphologically, the late outgrowth EPCs employed also showed an 
unexpected behaviour: the cells did not elongate themselves in the direction of flow, 
but became flat instead to escape the shear forces. Taken together, late outgrowth 
EPCs seem to be rather unsuitable for lining of tissue-engineered constructs as they 
lose their endothelial phenotype under shear stress exposure.  
There are several reports about positive paracrine influence of early EPCs on mature 
ECs in the literature. With the goal to address that issue, a feasibility study with the 
tissue-engineered BioStent construct was performed. HUVECs, which resemble the 
standard cell line for the lining of the BioStent, early EPCs and a mixture of early 
EPCs and HUVECs (ratio 1:1), were employed as linings for the stent. After one 
week of flow conditioning, HUVECs had formed a confluent layer of cells. The lining 
of the stent with a combination of HUVECs and EPCs was not confluent. In the 
approach with EPCs alone, only the cell layer of the underlying fibroblast cells, which 
are embedded in fibrin gel, was visible. In conclusion, no benefits of early EPCs for 
mature ECs could be observed. 
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Data in the current study was in most parts contradictory to literature. This could be 
attributed, to a certain extent, to the fact that the term “EPC” is used for cells from 
different origins. The present studies were performed with cells from peripheral blood 
of human donors, while in most previous studies, animal cells were used. Another 
aspect exacerbating the comparison is the fact that the source for EPCs can also be 
very diverse (umbilical blood, adult blood, spleen, bone marrow, etc.). This could be 
significantly compensated if there was a clear definition for the EPCs, which is still 
not the case. Moreover, the influence of turbulence on EPCs was not previously 
investigated, so there is no data for comparison on this issue. 
To conclude, late outgrowth EPCs lost their endothelial-like phenotype under the 
influence of shear stress, while early EPCs did not display any positive paracrine 
effects on mature endothelial cells. According to these results, EPCs, isolated from 
human peripheral blood, are not suitable for the lining of tissue-engineered 
constructs.  
These findings shall be proven and extended through additional studies in the future. 
The Taylor-Couette flow-based shear stress device, used for the present study, still 
has technical drawbacks as described in the discussion chapter. Therefore, it will be 
replaced by a redesigned model to overcome these problems and provide more 
reliable data in subsequent experiments. The following “outlook” chapter provides an 
overview of this new device. An additional issue described in that chapter is the 
development of an angular gear for tubing pumps. Tubing pumps are often used as 
drive for tissue engineering bioreactors. In the present work, a tubing pump served as 
drive for the parallel plate flow chamber. Operating a pump inside an incubator would 
lead to overheating which makes expensive and inconvenient cooling indispensable.  
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7. List of tables 
 
Table 1 from Resch et al. [44] and gives a summary over recent studies on EPC 
count and disease outcome. 18 
Table 2 from the publication of Sen et al. [58]  (modified) also takes the quality 
of EPCs into account, in addition to their count. 19 
Table 3 Primer list for GADPH, vWF, PECAM-1, eNOS, VEGFR-2, showing the 
sequence, melting temperature (Tm) and C/G content of the respective 
primer. 60 
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8. Appendix  
 
Medium for EPCs 
PromoCell GmbH, Sickingenstraße 63/65, D-69126 Heidelberg, Germany 
Endothelial Cell Basal Medium MV 2, phenol red-free 500 ml (cat.no.: C-22226)  
Endothelial Cell Growth Medium MV 2 SupplementPack 1 Pack (cat.no.: C-39221) 
without hydrocortisone. Supplemented with antibiotic.  
 
Medium for HUVECs 
Lonza Cologne GmbH, Nattermannallee 1, 50829 Cologne, Germany 
Endothel Cell Growth Medium 2 with supplements (EBM 2) 500ml (cat.no.: CC3162). 
Supplemented with antibiotic.  
   
Medium for Myofibroblasts 
Invitrogen from Life Technologies GmbH, Frankfurter Straße 129B, 64293 Darmstadt, 
Germany 
 
D-MEM (Dulbecco's Modified Eagle Medium) (1X), liquid (Low Glucose) (cat.no.: 
21885-108). Supplemented with antibiotic and approx. 10% FCS (fetal calf serum) 
 
PAA Laboratories GmbH, PAA-Strasse 1, 4061 Pasching, Austria 
FCS (cat.no.: A15-151) 
Medium for NO tests 
PromoCell GmbH, Sickingenstraße 63/65, D-69126 Heidelberg, Germany 
Endothelial Cell Basal Medium MV 2, phenol red-free 500 ml (cat.no.: C-22226)  
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Endothelial Cell Growth Medium MV 2 SupplementPack 1 Pack (cat.no.: C-39221) 
without hydrocortisone. Supplemented with antibiotic. Optionally supplemented with l-
arginine to increase nitrogen oxide production (various concentrations).  
 
Antibodies 
Anti CD31   (PECAM-1) antibody 
Sigma-Aldrich Chemie Gmbh, Eschenstraße 5, 82024 Taufkirchen,  Munich, 
Germany 
Monoclonal Anti-CD31 (PECAM-1) antibody produced in mouse (cat.no.: P8590) 
Anti CD309 (VEGF-R2) antibody 
Acris Antibodies GmbH, Schillerstraße 5, D-32052 Herford, Germany 
Poly-Rabbit-anti-Human CD309 / VEGFR-2 / Flk-1 antibody (cat.no.: NBP1-19479) 
Alexa Fluor labelled secondary antibodies  
Invitrogen from Life Technologies GmbH, Frankfurter Straße 129B, 64293 Darmstadt, 
Germany 
Alexa Fluor® 488 Goat Anti-Mouse IgG (H+L) *2 mg⁄mL (cat.no.: A-11001)  
Alexa Fluor® 594 Goat Anti-Rabbit IgG (H+L) *2 mg⁄mL (cat.no.: A-11012) 
Directly labelled anti CD309 (VEGF-R2) antibody for flow cytometry 
R&D Systems GmbH, Borsigstraße, 7a 65205 Wiesbaden-Nordenstadt, Germany 
Human VEGF R2/KDR allophycocyanin MAb (Clone 89106), mouse IgG1 (cat.no.: 
FAB357A) 
Isotypcontrole for mouse IgG1 (cat.no.: IC002A) 
Primers 
Eurofins MWG Operon, Anzingerstr. 7a, 85560 Ebersberg, Germany 
Chemical reagents 
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DAPI mounting medium 
Carl Roth GmbH + Co. KG,  Schoemperlenstraße 3,  76185 Karlsruhe,  
GermanyRoti®-Mount FluorCare DAPI (cat.no.: HP20.1) 
Chemicals for Isolation of EPCs 
Biochrom AG,Leonorenstr.2-6, 12247 Berlin, Germany 
Bicoll-Trennlösung  (cat.no.: L6115) 
Sigma-Aldrich Chemie Gmbh, Eschenstraße 5, 82024 Taufkirchen,  Munich, 
Germany 
Dextran (cat.no.: D1037) 
EIFELFANGO, Chem.-Pharm.-Werke, J. Graf Metternich GmbH & Co. KG, Ringener 
Straße 45, 53474 Bad Neuenahr-Ahrweiler, Germany 
Natriumcitratlösung 3,13%   (Eifelfango) 
Antibiotics 
Invitrogen from Life Technologies GmbH, Frankfurter Straße 129B, 64293 Darmstadt, 
Germany 
Penicillin - Streptomycin 100X Solution (10000 units) (cat.no.: 15140-130) 
Trypsin 
PAA Laboratories GmbH, PAA-Strasse 1, 4061 Pasching, Austria 
Trypsin EDTA (1x) (cat.no.: L 11-660) 
Accutase 
PAA Laboratories GmbH, PAA-Strasse 1, 4061 Pasching, Austria 
Accutase (cat.no.: L11-007) 
Fibronectin 
Tebu-bio,  Berliner Str. 255, 63067 Offenbach, Germany 
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Fibronectin human (cat.no.: 2003) 
Gelatine 
Sigma-Aldrich Chemie Gmbh, Eschenstraße 5, 82024 Taufkirchen,  Munich, 
Germany 
Gelatine (cat.no.: G9391) 
Galectin-8, galectin-3 
Both galectins were kind gifts of Christiane Kupper, from the group of Univ.-Prof. Dr. 
rer. nat. Lothar Elling (Laboratory for Biomaterials at the Department of 
Biotechnology and Helmholtz-Institute for Biomedical Engineering, RWTH Aachen, 
Germany) 
Bovine serum albumin 
Sigma-Aldrich Chemie Gmbh, Eschenstraße 5, 82024 Taufkirchen,  Munich, 
Germany 
Albumin from bovine serum (cat.no.: A2153-100G) 
Fixatives 
Sigma-Aldrich Chemie Gmbh, Eschenstraße 5, 82024 Taufkirchen,  Munich, 
Germany 
Methanol (cat.no.: 179337) 
Fluorescent staining agents 
DiI labled Ac-LDL: 
CellSystems Biotechnologie Vertrieb GmbH, Langeler Ring 5, D-53842 Troisdorf, 
Germany 
DiI-ac-LDL (cat.no.: CS-D-0120) 
FITC lablled UEA-1: 
Sigma-Aldrich Chemie Gmbh, Eschenstraße 5, 82024 Taufkirchen,  Munich, 
Germany 
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Lectin from Ulex europaeus (cat.no.: L9006) 
Reagents for real-time PCR 
Invitrogen from Life Technologies GmbH, Frankfurter Straße 129B, 64293 Darmstadt, 
Germany 
SUPERSCRIPT VILO CDNA SYNTHESIS KIT-50 RXN (cat.no.: 11754050) 
POWER SYBR GREEN PCR MASTER (cat.no.: 4368708) 
QIAGEN GmbH - Deutschland,  QIAGEN Strasse 1, 40724 Hilden, Germany 
RNase-Free DNase Set (50) 1500 units (cat.no.: 79254) 
Rneasy Plus Micro Kit (cat.no.: 74034) 
LumoxTM slide flasks 
SARSTEDT AG & Co. Sarstedtstraße, Postfach 1220, 51582 Nümbrecht, Germany 
LumoxTM slide flask (cat.no.: 94.6150.001) 
Gries reagents for nitrate oxide measurement 
Sigma-Aldrich Chemie Gmbh, Eschenstraße 5, 82024 Taufkirchen,  Munich, 
Germany 
NED (cat.no.:N9125) 
Phosphoric acid (cat.no.: 466123) 
Sulfanilic acid  (cat.no.: 46874) 
Buffers 
TBS 
Aqua dest 4 Liter 
Tris HCl     (Sigma, T3253)   17,44g 
Tris Base     (Sigma, T6066)    2,56g 
NaCl      (Sigma, S9625)    32,0g 
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KCl      (Merck, 1.04936.0500)   0,8g 
PBS  
KCl      (Merck, 1.04936.0500)   0,2g/l 
KH2PO4     (Merck, 104873)    0m2g/l 
NaCl      (Sigma, S9625)    8g/l 
Na2HPO4     (Roth, 6885.1)    1,15g/l 
PBS 
PBS (Ca and Mg free) 
PAA Laboratories GmbH, PAA-Strasse 1, 4061 Pasching, Austria   
PBS (cat.no.: H 15-002) 
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List of disposables 
name cat.no.: company 
10 ml syringe 3626823 BD 
50 ml syringe 8728810F Braun 
96 Well Plate 655180 Greiner 
tube ID 8.0mm SC 0587 Ismatec 
tube ID 6.4mm SC 0584 Ismatec 
tube ID 6.4mm MF 0013 Ismatec 
cell culture flask T25 690975 Greiner 
cell culture flask T75 658975 Greiner 
cell culture flask T175 660975 Greiner 
nunc triple flask F8667 Sigma 
sterilfilter 0.2µm gas SLFGL25BS Millipore 
sterile pipettes (5-50 ml) -  Sarstedt/Greiner 
 
Most disposables were ordered at the internal station (Fertigvorrat).  
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